Publications

Journals

• Chang SH; Johns M; Boyle JJ; McConnell E; Kirkham PA; Bicknell C; Zahoor-Ul-Hassan Dogar M; Edwards RJ; et alGale-Grant O; Khamis R; Ramkhelawon KV; Haskard DO. (Apr 2012). Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoprotein. Hybridoma (Larchmt). 31:87-98. DOI.
• Sennoga CA; Yeh JS; Alter J; Stride E; Nihoyannopoulos P; Seddon JM; Haskard DO; Hajnal JV; et alTang MX; Eckersley RJ. (May 2012). Evaluation of methods for sizing and counting of ultrasound contrast agents. Ultrasound Med Biol. 38:834-845. DOI.
• Lewis MJ; Malik TH; Fossati-Jimack L; Carassiti D; Terence Cook H; Haskard DO; Botto M. (5 Mar 2012). Combining lupus and hyperlipidaemia in mice reveals distinct roles for complement in glomerulonephritis and atherosclerosis. Arthritis Rheum. DOI.
• Dryden NH; Sperone A; Martin-Almedina S; Hannah RL; Birdsey GM; Khan ST; Layhadi JA; Mason JC; et alHaskard DO; Göttgens B; Randi AM. (6 Apr 2012). The Transcription Factor Erg Controls Endothelial Cell Quiescence by Repressing Activity of Nuclear Factor (NF)-κB p65. J Biol Chem. 287:12331-12342. DOI.
• Birdsey GM; Dryden NH; Shah AV; Hannah R; Hall MD; Haskard DO; Parsons M; Mason JC; et alZvelebil M; Gottgens B; Ridley AJ; Randi AM. (19 Jan 2012). The transcription factor Erg regulates expression of histone deacetylase 6 and multiple pathways involved in endothelial cell migration and angiogenesis. Blood. 119:894-903. DOI.
• Boyle JJ; Johns M; Kampfer T; Nguyen AT; Game L; Schaer DJ; Mason JC; Haskard DO. (6 Jan 2012). Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. Circ Res. 110:20-33. DOI.
• Al Jaaly E; Baig K; Patni R; Anderson J; Haskard DO. (Jul 2011). Surgical management of chylopericardium and chylothorax in a patient with Behçet's disease. Clin Exp Rheumatol. 29:S68-S70.
• Chan CF; Keenan NG; Lightman S; Haskard DO; Pennell DJ. (1 Oct 2011). INTERFERON-alpha REDUCES EARLY ATHEROSCLEROSIS IN PATIENTS WITH BEHCET'S SYNDROME. HEART. 97:18-19. Author weblink DOI.
• Khamis RY; Johns M; Thom S; Mayet J; McConnell E; Stanton A; Jeyapalan S; Annon S; et alWrigley S; Hughes A; Haskard DO. (1 Oct 2011). IGG ANTI-MALONEDIALDEHYDE-LDL ANTIBODIES ARE ASSOCIATED WITH LOW RISK OF CARDIOVASCULAR EVENTS IN A SUBSTUDY OF THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT), AND ARE UNRELATED TO LDL, CRP LEVELS AND STATIN TREATMENT. HEART. 97:5-5. Author weblink DOI.
• Paschalaki K; Starke RD; Mercado N; Haskard DO; Barnes PJ; Randi AM. (1 Oct 2011). ENDOTHELIAL COLONY FORMING CELLS (ECFC) ARE SENESCENT AND DYSFUNCTIONAL IN COPD DUE TO REDUCED SIRTUIN-1 LEVELS. HEART. 97:20-20. Author weblink DOI.
• Starke RD; Paschalaki KE; Ferraro F; Dryden NH; McKinnon TA; Sutton RE; Payne EM; Haskard DO; et alHughes AD; Cutler DF; Laffan MA; Randi AM. (Oct 2011). 39 Blood-derived endothelial progenitor cells from Von Willebrand's disease patients demonstrate that Von Willebrand factor regulates angiogenesis. Heart. 97:e7. DOI.
• Boyle JJ; Johns M; Lo J; Chiodini A; Ambrose N; Evans PC; Mason JC; Haskard DO. (Nov 2011). Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 31:2685-2691. DOI.
• Mason JC; Ahmad SR; Lidington EA; Ohta R; Okada N; Davies KA; Haskard DO. (1 Apr 2003). THE COMPLEMENT REGULATORY PROTEIN DECAY-ACCELERATING FACTOR (DAF) IS UPREGULATED ON MURINE VASCULAR ENDOTHELIUM IN VITRO AND DURING GLOMERULONEPHRITIS IN VIVO. RHEUMATOLOGY. 42:124-124. Author weblink.
• Philippidis P; Evans BJ; Mason JC; Taylor KM; Haskard DO; Landis C. (1 Apr 2004). THE HAEMOGLOBIN SCAVENGER RECEPTOR CD163 MEDIATES MACROPHAGE INTERLEUKIN-10 AND HAEM OXYGENASE-1 SYNTHESIS: AN INDUCIBLE CYTOPROTECTIVE PATHWAY AGAINST HAEMOGLOBIN-MEDIATED OXIDATIVE VASCULAR INJURY. RHEUMATOLOGY. 43:8-8. Author weblink.
• Haskard DO. (1 Jul 2005). IMAGING ENDOTHELIAL ACTIVATION IN INFLAMMATION. RHEUMATOLOGY. 44:9-9. Author weblink DOI.
• Andrews J; Malik IS; Davies K; Haskard DO; Mason JC. (1 Apr 2002). EVALUATION OF FDG-PET AND MR IMAGING IN TAKAYASU'S ARTERITIS. RHEUMATOLOGY. 41:19-19. Author weblink.
• Florey O; Mason JC; Haskard DO. (1 Apr 2004). LIGATION OF LEUKOCYTE FC gamma RII (CD32) BY AN ANTI-ENDOTHELIAL CELL (EC) ANTIBODY SYNERGISES WITH G-PROTEIN COUPLED RECEPTOR SIGNALLING TO AMPLIFY LEUKOCYTE ADHESION TO CYTOKINE-ACTIVATED UNDER PHYSIOLOGICAL FLOW. RHEUMATOLOGY. 43:30-31. Author weblink.
• Bussolati B; Ahmed A; Landis RC; Di Carlo F; Pemberton H; Haskard DO; Mason JC. (1 Apr 2004). BIFUNCTIONAL ROLE FOR VEGF-INDUCED HEME OXYGENASE-1 IN VIVO: INDUCTION OF ANGIOGENESIS AND INHIBITION OF LEUKOCYTIC INFILTRATION. RHEUMATOLOGY. 43:30-30. Author weblink.
• Mason JC; Lidington EA; Mankoff R; Kinderlerer AR; Ohba M; Haskard DO. (1 Apr 2004). VEGF-INDUCED CYTOPROTECTION OF VASCULAR ENDOTHELIUM IS DIFFERENTIALLY REGULATED BY CYCLOSPORIN A AND RAPAMYCIN. RHEUMATOLOGY. 43:30-30. Author weblink.
• Nadra I; Mason JC; McCarthy GM; Landis C; Haskard DO. (1 Apr 2004). BASIC CALCIUM PHOSPHATE CRYSTAL-INDUCED SECRETION OF PRO-INFLAMMATORY CYTOKINES BY HUMAN MONOCYTE/MACROPHAGES LEADING TO ENDOTHELIAL ACTIVATION MEDIATED THROUGH PROTEIN KINASE C alpha AND epsilon, MEK-1/2 MAP KINASE AND NF kappa B INTRACELLULAR SIGNALING PATHWAYS. RHEUMATOLOGY. 43:55-55. Author weblink.
• Kinderlerer AR; Mankoff R; Maxwell PH; Haskard DO; Mason JC. (1 Apr 2004). UPREGULATION OF MEMBRANE-BOUND COMPLEMENT REGULATORY PROTEINS BY ATORVASTATIN PROTECTS VASCULAR ENDOTHELIUM AGAINST COMPLEMENT-MEDIATED INJURY DURING HYPOXIA-REOXYGENATION. RHEUMATOLOGY. 43:8-8. Author weblink.
• Lidington EA; Rao RM; Marelli-Berg F; Jat P; Haskard DO; Mason JC. (1 Apr 2001). Isolation and characterisation of conditionally immortal growth factor responsive cardiac endothelial cells (EC) from H-2K(b)-tsA58 transgenic mice. RHEUMATOLOGY. 40:8-8. Author weblink.
• Yagnik DR; Evans BJ; Landis C; Haskard DO. (1 Apr 2004). MONOCYTE-MACROPHAGE DIFFERENTIATION IN VIVO AND THE CONTROL OF MONOSODIUM URATE (MSU) CRYSTAL-STIMULATED INFLAMMATION. RHEUMATOLOGY. 43:4-4. Author weblink.
• Rao RM; Clarke JL; Ortlepp S; Robinson MK; Landis RC; Haskard DO. (1 Apr 2001). The S128R polymorphism of E-selectin mediates increased recruitment of leucocytes under flow conditions. RHEUMATOLOGY. 40:64-65. Author weblink.
• Marshall D; Dangerfield JD; Bhatia VK; Larbi KY; Nourshargh S; Haskard DO. (1 Apr 2002). MRL/lpr LUPUS-PRONE MICE SHOW EXAGGERATED ICAM-1 DEPENDENT LEUKOCYTE-ENDOTHELIAL INTERACTIONS IN RESPONSE TO TNF alpha. RHEUMATOLOGY. 41:32-32. Author weblink.
• Yagnik DR; Mason JC; Landis C; Haskard DO. (1 Apr 2003). DIFFERENTIATION OF MONOCYTES TO MACROPHAGES ALTERS CYTOKINE RELEASE IN RESPONSE TO MONOSODIUM URATE (MSU) CRYSTALS: ROLE OF MACROPHAGE TGF-BETA 1 IN THE RESOLUTION OF ACUTE GOUT. RHEUMATOLOGY. 42:4-5. Author weblink.
• Landis RC; Yagnik D; Haskard DO. (1 Apr 2001). The state of monocyte/macrophage differentiation determines the inflammatory cytokine response to monosodium urate (MSU) crystals. RHEUMATOLOGY. 40:67-67.
• Mason JC; Ahmed Z; Lidington EA; Mankoff R; Ahmad SR; Randi A; Haskard DO. (1 Apr 2002). STATIN-INDUCED EXPRESSION OF COMPLEMENT INHIBITORY PROTEINS PROTECTS VASCULAR ENDOTHELIUM AGAINST COMPLEMENT-MEDIATED INJURY. RHEUMATOLOGY. 41:8-8.
• Schreiber BE; Noor N; Juli CF; Haskard DO. (Dec 2011). Resolution of Behçet's syndrome associated pulmonary arterial aneurysms with infliximab. Semin Arthritis Rheum. 41:482-487. DOI.
• Cuhlmann S; Van der Heiden K; Saliba D; Tremoleda JL; Khalil M; Zakkar M; Chaudhury H; Luong LEA; et alMason JC; Udalova I; Gsell W; Jones H; Haskard DO; Krams R; Evans PC. (15 Apr 2011). Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-κB regulation that promotes arterial inflammation. Circ Res. 108:950-959. DOI.
• Zakkar M; Luong LEA; Chaudhury H; Ruud O; Punjabi PP; Anderson JR; Mullholand JW; Clements AT; et alKrams R; Foin N; Athanasiou T; Leen EL; Mason JC; Haskard DO; Evans PC. (8 Feb 2011). Dexamethasone arterializes venous endothelial cells by inducing mitogen-activated protein kinase phosphatase-1: a novel antiinflammatory treatment for vein grafts?. Circulation. 123:524-532. DOI.
• Iqbal MB; Boyle JJ; Laffan MA; Haskard DO. (1 Jul 2010). DEXAMETHASONE EXERTS DUAL ACTIONS IN REDUCING MONOCYTE THROMBOGENIC PROFILE BY ENHANCING FIBRINOLYTIC ACTIVITY AND REDUCING PROCOAGULANT ACTIVITY. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 28:S156-S156. Author weblink.
• Starke RD; Ferraro F; Paschalaki KE; Dryden NH; McKinnon TA; Sutton RE; Payne EM; Haskard DO; et alHughes AD; Cutler DF; Laffan MA; Randi AM. (20 Jan 2011). Endothelial von Willebrand factor regulates angiogenesis. Blood. 117:1071-1080. DOI.
• Sperone A; Dryden NH; Birdsey GM; Madden L; Johns M; Evans PC; Mason JC; Haskard DO; et alBoyle JJ; Paleolog EM; Randi AM. (Jan 2011). The transcription factor Erg inhibits vascular inflammation by repressing NF-kappaB activation and proinflammatory gene expression in endothelial cells. Arterioscler Thromb Vasc Biol. 31:142-150. DOI.
• Malik TH; Cortini A; Carassiti D; Boyle JJ; Haskard DO; Botto M. (9 Nov 2010). The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation. 122:1948-1956. DOI.
• Gompels LL; Madden L; Lim NH; Inglis JJ; McConnell E; Vincent TL; Haskard DO; Paleolog EM. (Jan 2011). In vivo fluorescence imaging of E-selectin: quantitative detection of endothelial activation in a mouse model of arthritis. Arthritis Rheum. 63:107-117. DOI.
• Jevon M; Ansari TI; Finch J; Zakkar M; Evans PC; Shurey S; Sibbons PD; Hornick P; et alHaskard DO; Dorling A. (May 2011). Smooth muscle cells in porcine vein graft intimal hyperplasia are derived from the local vessel wall. Cardiovasc Pathol. 20:e91-e94. DOI.
• Mehta P; Laffan M; Haskard DO. (Nov 2010). Thrombosis and Behçet's syndrome in non-endemic regions. Rheumatology (Oxford). 49:2003-2004. DOI.
• Landis RC; Evans BJ; Chaturvedi N; Haskard DO. (Jul 2010). Persistence of TNFalpha in diabetic wounds. Diabetologia. 53:1537-1538. DOI.
• Schreiber BE; Agrup C; Haskard DO; Luxon LM. (3 Apr 2010). Sudden sensorineural hearing loss. Lancet. 375:1203-1211. DOI.
• Philippidis P; Athanasiou T; Nadra I; Ashrafian H; Haskard DO; Landis RC; Taylor KM. (Jun 2010). Anti-inflammatory haemoglobin scavenging monocytes are induced following coronary artery bypass surgery. Eur J Cardiothorac Surg. 37:1360-1366. DOI.
• Hamdulay SS; Wang B; Birdsey GM; Ali F; Dumont O; Evans PC; Haskard DO; Wheeler-Jones CP; et alMason JC. (15 Apr 2010). Celecoxib activates PI-3K/Akt and mitochondrial redox signaling to enhance heme oxygenase-1-mediated anti-inflammatory activity in vascular endothelium. Free Radic Biol Med. 48:1013-1023. DOI.
• Chaudhury H; Zakkar M; Boyle J; Cuhlmann S; van der Heiden K; Luong LEA; Davis J; Platt A; et alMason JC; Krams R; Haskard DO; Clark AR; Evans PC. (Mar 2010). c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis. Arterioscler Thromb Vasc Biol. 30:546-553. DOI.
• Ali F; Ali NS; Bauer A; Boyle JJ; Hamdulay SS; Haskard DO; Randi AM; Mason JC. (1 Mar 2010). PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress. Cardiovasc Res. 85:701-710. DOI.
• Leung VWY; Yun S; Botto M; Mason JC; Malik TH; Song W; Paixao-Cavalcante D; Pickering MC; et alBoyle JJ; Haskard DO. (1 Oct 2009). Decay-Accelerating Factor Suppresses Complement C3 Activation and Retards Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. AMERICAN JOURNAL OF PATHOLOGY. 175:1757-1767. Author weblink DOI.
• Zakkar M; Van der Heiden K; Luong LEA; Chaudhury H; Cuhlmann S; Hamdulay SS; Krams R; Edirisinghe I; et alRahman I; Carlsen H; Haskard DO; Mason JC; Evans PC. (Nov 2009). Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol. 29:1851-1857. DOI.
• Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO. (4 Aug 2009). Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. CIRCULATION. 120:417-U101. Author weblink DOI.
• Garrood T; Blades M; Haskard DO; Mather S; Pitzalis C. (1 Aug 2009). A novel model for the pre-clinical imaging of inflamed human synovial vasculature. RHEUMATOLOGY. 48:926-931. Author weblink DOI.
• Florey O; Haskard DO. (15 Aug 2009). Sphingosine 1-phosphate enhances Fc gamma receptor-mediated neutrophil activation and recruitment under flow conditions. J Immunol. 183:2330-2336. DOI.
• Theoharis S; Krueger U; Tan PH; Haskard DO; Weber M; George AJT. (15 Apr 2009). Targeting gene delivery to activated vascular endothelium using anti E/P-Selectin antibody linked to PAMAM dendrimers. JOURNAL OF IMMUNOLOGICAL METHODS. 343:79-90. DOI.
• Ali F; Zakkar M; Karu K; Lidington EA; Hamdulay SS; Boyle JJ; Zloh M; Bauer A; et alHaskard DO; Evans PC; Mason JC. (10 Jul 2009). Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by disturbed flow. J Biol Chem. 284:18882-18892. DOI.
• Killock DJ; Parsons M; Zarrouk M; Ameer-Beg SM; Ridley AJ; Haskard DO; Zvelebil M; Ivetic A. (27 Mar 2009). In Vitro and in Vivo Characterization of Molecular Interactions between Calmodulin, Ezrin/Radixin/Moesin, and L-selectin. JOURNAL OF BIOLOGICAL CHEMISTRY. 284:8824-8836. Author weblink DOI.
• Kinderlerer AR; Gregoire IP; Hamdulay SS; Ali F; Steinberg R; Silva G; Ali N; Wang B; et alHaskard DO; Soares MP; Mason JC. (12 Feb 2009). Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin. BLOOD. 113:1598-1607. Author weblink DOI.
• Boyle JJ; Harrington HA; Piper E; Elderfield K; Stark J; Landis RC; Haskard DO. (Mar 2009). Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol. 174:1097-1108. DOI.
• Zakkar M; Chaudhury H; Sandvik G; Enesa K; Luong LA; Cuhlmann S; Mason JC; Krams R; et alClark AR; Haskard DO; Evans PC. (26 Sep 2008). Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. CIRCULATION RESEARCH. 103:726-732. Author weblink DOI.
• Lutz J; Luong LEA; Strobl M; Deng M; Huang H; Anton M; Zakkar M; Enesa K; et alChaudhury H; Haskard DO; Baumann M; Boyle J; Harten S; Maxwell PH; Pusey C; Heemann U; Evans PC. (Dec 2008). The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J Mol Med (Berl). 86:1329-1339. DOI.
• Zakkar M; Chaudhury H; Punjabi PP; Haskard DO; Evans PC. (1 Sep 2008). Acute high shear stress activates venous but not arterial endothelial cells by signalling through the p38 MAP kinase pathway. HEART. 94. Author weblink.
• Haskard DO; Boyle JJ; Mason JC. (Oct 2008). The role of complement in atherosclerosis. Curr Opin Lipidol. 19:478-482. DOI.
• Hamdulay SS; Cheent K; Ghosh C; Stocks J; Ghosh S; Haskard DO. (1 Aug 2008). Wireless capsule endoscopy in the investigation of intestinal Behcet's syndrome. RHEUMATOLOGY. 47:1231-1234. Author weblink DOI.
• Enesa K; Ito K; Luong LA; Thorbjornsen I; Phua C; To Y; Dean J; Haskard DO; et alBoyle J; Adcock I; Evans PC. (4 Jul 2008). Hydrogen peroxide prolongs nuclear localization of NF-kappa B in activated cells by suppressing negative regulatory mechanisms. JOURNAL OF BIOLOGICAL CHEMISTRY. 283:18582-18590. DOI.
• Yun S; Leung VW; Botto M; Boyle JJ; Haskard DO. (Oct 2008). Brief report: accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59. Arterioscler Thromb Vasc Biol. 28:1714-1716. DOI.
• Kinderlerer AR; Ali F; Johns M; Lidington EA; Leung V; Boyle JJ; Hamdulay SS; Evans PC; et alHaskard DO; Mason JC. (23 May 2008). KLF2-dependent, shear stress-induced expression of CD59 - A novel cytoprotective mechanism against complement-mediated injury in the vasculature. JOURNAL OF BIOLOGICAL CHEMISTRY. 283:14636-14644. Author weblink DOI.
• Dalbeth N; Smith T; Nicolson B; Clark B; Callon K; Naot D; Haskard DO; McQueen FM; et alReid IR; Cornish J. (Jun 2008). Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells. Arthritis Rheum. 58:1854-1865. DOI.
• Evans BJ; Haskard DO; Finch JR; Hambleton IR; Landis RC; Taylor KM. (1 May 2008). The inflammatory effect of cardiopulmonary bypass on leukocyte extravasation in vivo. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 135:999-1006. Author weblink DOI.
• Enesa K; Zakkar M; Chaudhury H; Luong LA; Rawlinson L; Mason JC; Haskard DO; Dean JLE; et alEvans PC. (14 Mar 2008). NF-kappa B suppression by the deubiquitinating enzyme Cezanne - A novel negative feedback loop in pro-inflammatory signaling. JOURNAL OF BIOLOGICAL CHEMISTRY. 283:7036-7045. Author weblink DOI.
• Birdsey GM; Dryden NH; Amsellem V; Gebhardt F; Sahnan K; Haskard DO; Dejana E; Mason JC; et alRandi AM. (1 Apr 2008). Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood. 111:3498-3506. DOI.
• Ali F; Hamdulay SS; Kinderlerer AR; Boyle JJ; Lidington EA; Yamaguchi T; Soares MP; Haskard DO; et alRandi AM; Mason JC. (1 Dec 2007). Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 5:2537-2546. Author weblink DOI.
• Steinberg R; Harari OA; Lidington EA; Boyle JJ; Nohadani M; Samarel AM; Ohba M; Haskard DO; et alMason JC. (2 Nov 2007). A protein kinase C epsilon-anti-apoptotic kinase signaling complex protects human vascular endothelial cells against apoptosis through induction of Bcl-2. JOURNAL OF BIOLOGICAL CHEMISTRY. 282:32288-32297. Author weblink DOI.
• Florey O; Haskard DO. (2007). Analysis of flow-based adhesion in vitro. Methods Mol Med. 135:323-331.
• Woodfin A; Reichel CA; Khandoga A; Corada M; Voisin M-B; Scheiermann C; Haskard DO; Dejana E; et alKrombach F; Nourshargh S. (15 Sep 2007). JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. BLOOD. 110:1848-1856. Author weblink DOI.
• Smythe CDW; Haskard DO. (2001). ACE inhibition: promiscuity can be protective!. Int J Cardiol. 81:115-116.
• Partridge J; Carlsen H; Enesa K; Chaudhury H; Zakkar M; Luong L; Kinderlerer A; Johns M; et alBlomhoff R; Mason JC; Haskard DO; Evans PC. (Nov 2007). Laminar shear stress acts as a switch to regulate divergent functions of NF-kappaB in endothelial cells. FASEB J. 21:3553-3561. DOI.
• Galkina E; Florey O; Zarbock A; Smith BR; Preece G; Lawrence MB; Haskard DO; Ager A. (May 2007). T lymphocyte rolling and recruitment into peripheral lymph nodes is regulated by a saturable density of L-selectin (CD62L). Eur J Immunol. 37:1243-1253. DOI.
• Nadra I; Boccaccini AR; Philippidis P; Whelan LC; McCarthy GM; Haskard DO; Landis RC. (Jan 2008). Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages. Atherosclerosis. 196:98-105. DOI.
• Florey OJ; Johns M; Esho OO; Mason JC; Haskard DO. (1 May 2007). Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc{gamma}RIIa and CXCR1/2. Blood. 109:3881-3889. DOI.
• Bhatia VK; Yun S; Leung V; Grimsditch DC; Benson GM; Botto MB; Boyle JJ; Haskard DO. (Jan 2007). Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol. 170:416-426. DOI.
• Alam AK; Florey O; Weber M; Pillai RG; Chan C; Tan PH; Lechler RI; McClure MO; et alHaskard DO; George AJ. (Nov 2006). Knockdown of mouse VCAM-1 by vector-based siRNA. Transpl Immunol. 16:185-193. DOI.
• George AJ; Bhakoo KK; Haskard DO; Larkman DJ; Reynolds PR. (15 Nov 2006). Imaging molecular and cellular events in transplantation. Transplantation. 82:1124-1129. DOI.
• Reynolds PR; Larkman DJ; Haskard DO; Hajnal JV; Kennea NL; George AJ; Edwards AD. (Nov 2006). Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology. 241:469-476. DOI.
• Hepburn AL; Mason JC; Wang S; Shepherd CJ; Florey O; Haskard DO; Davies KA. (Oct 2006). Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro. Clin Exp Immunol. 146:133-145. DOI.
• Kinderlerer AR; Steinberg R; Johns M; Harten SK; Lidington EA; Haskard DO; Maxwell PH; Mason JC. (2006). Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis. Arthritis Res Ther. 8:R130. DOI.
• Garden OA; Reynolds PR; Yates J; Larkman DJ; Marelli-Berg FM; Haskard DO; Edwards AD; George AJ. (31 Jul 2006). A rapid method for labelling CD4+ T cells with ultrasmall paramagnetic iron oxide nanoparticles for magnetic resonance imaging that preserves proliferative, regulatory and migratory behaviour in vitro. J Immunol Methods. 314:123-133. DOI.
• Huang MT; Larbi KY; Scheiermann C; Woodfin A; Gerwin N; Haskard DO; Nourshargh S. (15 Jun 2006). ICAM-2 mediates neutrophil transmigration in vivo: evidence for stimulus specificity and a role in PECAM-1-independent transmigration. Blood. 107:4721-4727. DOI.
• Day JR; Haskard DO; Taylor KM; Landis RC. (Feb 2006). Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation. Ann Thorac Surg. 81:619-624. DOI.
• Evans BJ; McDowall A; Taylor PC; Hogg N; Haskard DO; Landis RC. (1 May 2006). Shedding of lymphocyte function-associated antigen-1 (LFA-1) in a human inflammatory response. Blood. 107:3593-3599. DOI.
• Day JR; Taylor KM; Lidington EA; Mason JC; Haskard DO; Randi AM; Landis RC. (Jan 2006). Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1. J Thorac Cardiovasc Surg. 131:21-27. DOI.
• Lidington EA; Steinberg R; Kinderlerer AR; Landis RC; Ohba M; Samarel A; Haskard DO; Mason JC. (Dec 2005). A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells. Am J Physiol Cell Physiol. 289:C1437-C1447. DOI.
• Cope AP; Brennan FM; Hill Gaston JS; Haskard DO. (Nov 2005). Planning your research training. Rheumatology (Oxford). 44:1339-1340. DOI.
• Huang MT; Mason JC; Birdsey GM; Amsellem V; Gerwin N; Haskard DO; Ridley AJ; Randi AM. (1 Sep 2005). Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis. Blood. 106:1636-1643. DOI.
• Dalbeth N; Haskard DO. (Sep 2005). Mechanisms of inflammation in gout. Rheumatology (Oxford). 44:1090-1096. DOI.
• Nadra I; Mason JC; Philippidis P; Florey O; Smythe CD; McCarthy GM; Landis RC; Haskard DO. (24 Jun 2005). Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?. Circ Res. 96:1248-1256. DOI.
• Dalbeth N; Haskard DO. (May 2005). Inflammation and tissue damage in crystal deposition diseases. Curr Opin Rheumatol. 17:314-318.
• Wibaut-Berlaimont V; Randi AM; Mandryko V; Lunnon MW; Haskard DO; Naoumova RP. (Apr 2005). Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis. J Thromb Haemost. 3:677-685. DOI.
• Cardozo LA; Rouw DB; Ambrose LR; Midulla M; Florey O; Haskard DO; Warrens AN. (27 Dec 2004). The neutrophil: the unnoticed threat in xenotransplantation?. Transplantation. 78:1721-1728.
• Day JR; Punjabi PP; Randi AM; Haskard DO; Landis RC; Taylor KM. (26 Oct 2004). Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery. Circulation. 110:2597-2600. DOI.
• Mason JC; Steinberg R; Lidington EA; Kinderlerer AR; Ohba M; Haskard DO. (1 Oct 2004). Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha/epsilon (PKCalpha/epsilon)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A. J Biol Chem. 279:41611-41618. DOI.
• Ivetic A; Florey O; Deka J; Haskard DO; Ager A; Ridley AJ. (6 Aug 2004). Mutagenesis of the ezrin-radixin-moesin binding domain of L-selectin tail affects shedding, microvillar positioning, and leukocyte tethering. J Biol Chem. 279:33263-33272. DOI.
• Andrews J; Al-Nahhas A; Pennell DJ; Hossain MS; Davies KA; Haskard DO; Mason JC. (Aug 2004). Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. 63:995-1000. DOI.
• Day JR; Malik IS; Weerasinghe A; Poullis M; Nadra I; Haskard DO; Taylor KM; Landis RC. (Jul 2004). Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention. Heart. 90:794-799. DOI.
• Yagnik DR; Evans BJ; Florey O; Mason JC; Landis RC; Haskard DO. (Jul 2004). Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 50:2273-2280. DOI.
• Tan PH; Chan C; Xue SA; Dong R; Ananthesayanan B; Manunta M; Kerouedan C; Cheshire NJ; et alWolfe JH; Haskard DO; Taylor KM; George AJ. (Apr 2004). Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. Atherosclerosis. 173:171-183. DOI.
• Stefanou DC; Asimakopoulos G; Yagnik DR; Haskard DO; Anderson JR; Philippidis P; Landis RC; Taylor KM. (Mar 2004). Monocyte Fc gamma receptor expression in patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 77:951-955. DOI.
• Bussolati B; Ahmed A; Pemberton H; Landis RC; Di Carlo F; Haskard DO; Mason JC. (1 Feb 2004). Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood. 103:761-766. DOI.
• Philippidis P; Mason JC; Evans BJ; Nadra I; Taylor KM; Haskard DO; Landis RC. (9 Jan 2004). Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res. 94:119-126. DOI.
• Haskard DO. (2004). Accelerated atherosclerosis in inflammatory rheumatic diseases. Scand J Rheumatol. 33:281-292. DOI.
• Galkina E; Tanousis K; Preece G; Tolaini M; Kioussis D; Florey O; Haskard DO; Tedder TF; et alAger A. (3 Nov 2003). L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes. J Exp Med. 198:1323-1335. DOI.
• Ahmad SR; Lidington EA; Ohta R; Okada N; Robson MG; Davies KA; Leitges M; Harris CL; et alHaskard DO; Mason JC. (Oct 2003). Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition. Immunology. 110:258-268.
• Smythe CD; Skinner VO; Bruckdorfer KR; Haskard DO; Landis RC. (Oct 2003). The state of macrophage differentiation determines the TNF alpha response to nitrated lipoprotein uptake. Atherosclerosis. 170:213-221.
• Marshall D; Dangerfield JP; Bhatia VK; Larbi KY; Nourshargh S; Haskard DO. (Aug 2003). MRL/lpr lupus-prone mice show exaggerated ICAM-1-dependent leucocyte adhesion and transendothelial migration in response to TNF-alpha. Rheumatology (Oxford). 42:929-934. DOI.
• Tan PH; Manunta M; Ardjomand N; Xue SA; Larkin DF; Haskard DO; Taylor KM; George AJ. (Apr 2003). Antibody targeted gene transfer to endothelium. J Gene Med. 5:311-323. DOI.
• Larbi KY; Dangerfield JP; Culley FJ; Marshall D; Haskard DO; Jose PJ; Williams TJ; Nourshargh S. (Jan 2003). P-selectin mediates IL-13-induced eosinophil transmigration but not eotaxin generation in vivo: a comparative study with IL-4-elicited responses. J Leukoc Biol. 73:65-73.
• Marshall D; Haskard DO. (2003). Quantifying inflammation in vivo using radiolabeled antibodies and leukocytes. Methods Mol Biol. 225:273-282. DOI.
• Rao RM; Haskard DO; Landis RC. (15 Nov 2002). Enhanced recruitment of Th2 and CLA-negative lymphocytes by the S128R polymorphism of E-selectin. J Immunol. 169:5860-5865.
• Landis RC; Yagnik DR; Florey O; Philippidis P; Emons V; Mason JC; Haskard DO. (Nov 2002). Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum. 46:3026-3033. DOI.
• Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; et alHaskard DO. (18 Oct 2002). Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury. Circ Res. 91:696-703.
• Andrews J; Haskard DO. (Oct 2002). Current management options in Behçet's disease. Minerva Med. 93:335-345.
• Smyth CL; Pusey CD; Haskard DO. (1 Sep 2002). ANCA induce leucocyte adhesion to endothelial cells mediated by E-selectin and integrins under conditions of flow. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 13:170A-170A. Author weblink.
• Smyth CL; Smith J; Cook HT; Haskard DO; Pusey CD. (1 Sep 2002). Immunisation with MPO directly induces small vessel vasculitis with Pauci-immune focal segmental glomerulonephritis and alveolar haemorrhage in WKY rats. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 13:170A-170A. Author weblink.
• Blades MC; Manzo A; Ingegnoli F; Taylor PR; Panayi GS; Irjala H; Jalkanen S; Haskard DO; et alPerretti M; Pitzalis C. (1 May 2002). Stromal cell-derived factor 1 (CXCL12) induces human cell migration into human lymph nodes transplanted into SCID mice. J Immunol. 168:4308-4317.
• Marshall D; Haskard DO. (Apr 2002). Clinical overview of leukocyte adhesion and migration: where are we now?. Semin Immunol. 14:133-140. DOI.
• Khan AI; Haskard DO; Malhotra R; Landis RC. (Apr 2002). Identification and characterization of L-selectin ligands in porcine lymphoid tissues. Immunology. 105:441-449.
• Reynolds PR; Larkman DJ; Hajnal JV; Haskard DO; Edwards D; George ALT. (1 Apr 2002). Magnetic resonance imaging of inflammation: Superparamagnetic nanoparticles can be targeted to E-selectin using a monoclonal antibody. PEDIATRIC RESEARCH. 51:12A-12A. Author weblink.
• Mason JC; Lidington EA; Ahmad SR; Haskard DO. (Mar 2002). bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction. Am J Physiol Cell Physiol. 282:C578-C587. DOI.
• Lidington EA; Rao RM; Marelli-Berg FM; Jat PS; Haskard DO; Mason JC. (Jan 2002). Conditional immortalization of growth factor-responsive cardiac endothelial cells from H-2K(b)-tsA58 mice. Am J Physiol Cell Physiol. 282:C67-C74.
• Haskard DO; Landis RC. (2002). Interactions between leukocytes and endothelial cells in gout: lessons from a self-limiting inflammatory response. Arthritis Res. 4 Suppl 3:S91-S97.
• Jamar F; Houssiau FA; Devogelaer JP; Chapman PT; Haskard DO; Beaujean V; Beckers C; Manicourt DH; et alPeters AM. (Jan 2002). Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology (Oxford). 41:53-61.
• Rao RM; Clarke JL; Ortlepp S; Robinson MK; Landis RC; Haskard DO. (Jan 2002). The S128R polymorphism of E-selectin mediates neuraminidase-resistant tethering of myeloid cells under shear flow. Eur J Immunol. 32:251-260. DOI.
• Landis RC; Asimakopoulos G; Poullis M; Haskard DO; Taylor KM. (Dec 2001). The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg. 72:2169-2175.
• Landis RC; Haskard DO; Taylor KM. (Nov 2001). New antiinflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg. 72:S1808-S1813.
• Malik I; Danesh J; Whincup P; Bhatia V; Papacosta O; Walker M; Lennon L; Thomson A; et alHaskard D. (22 Sep 2001). Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet. 358:971-976. DOI.
• Mason JC; Ahmed Z; Randi A; Haskard DO. (1 Sep 2001). Atorvastatin protects vascular endothelium against complement-mediated injury through upregulation of membrane bound complement inhibitory proteins. ARTHRITIS AND RHEUMATISM. 44:S396-S396. Author weblink.
• Chambers JC; Kooner JS; DeSwiet M; Fusi L; Jean-Marie J; McGregor A; Malik I; Haskard DO. (1 Sep 2001). Evidence for novel maternal mechanisms underlying pre-eclampsia. EUROPEAN HEART JOURNAL. 22:459-459. Author weblink.
• Landis RC; Yagnik D; Emons E; Mason JC; Haskard DO. (1 Sep 2001). Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. ARTHRITIS AND RHEUMATISM. 44:S162-S162. Author weblink.
• Rao RM; Haskard DO; Landis RC. (1 Sep 2001). The S128R polymorphism of E-selectin alters the specificity of its interactions with lymphocytes. ARTHRITIS AND RHEUMATISM. 44:S302-S302. Author weblink.
• Harari OA; Marshall D; McHale JF; Ahmed S; Haskard DO. (Aug 2001). Limited endothelial E- and P-selectin expression in MRL/lpr lupus-prone mice. Rheumatology (Oxford). 40:889-895.
• Asimakopoulos G; Lidington EA; Mason J; Haskard DO; Taylor KM; Landis RC. (Jul 2001). Effect of aprotinin on endothelial cell activation. J Thorac Cardiovasc Surg. 122:123-128. DOI.
• Pollak L; Luxon LM; Haskard DO. (Jul 2001). Labyrinthine involvement in Behçet's syndrome. J Laryngol Otol. 115:522-529.
• Bhatia VK; Haskard DO. (Jun 2001). Markers of inflammation in unstable angina. Heart. 85:603-604.
• Chambers JC; Fusi L; Malik IS; Haskard DO; De Swiet M; Kooner JS. (28 Mar 2001). Association of maternal endothelial dysfunction with preeclampsia. JAMA. 285:1607-1612.
• Mason JC; Lidington EA; Rao RM; Marelli-Berg FM; Jat PS; Haskard DO. (8 Mar 2001). Use of H-2Kb-tsA58 transgenic mice to generate conditionally immortalized, growth factor responsive mouse cardiac endothelial cells for in vitro studies. FASEB JOURNAL. 15:A947-A947. Author weblink.
• Marshall D; Bhatia VK; Ahmed S; Lidington EA; Larbi KY; Nourshargh S; Haskard DO. (7 Mar 2001). Expression of P- but not E-selectin in peritoneal microvasculature during inflammatory peritonitis. FASEB JOURNAL. 15:A328-A328. Author weblink.
• Landis RC; Haskard DO. (Feb 2001). Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep. 3:36-41.
• Chambers JC; Haskard DO; Kooner JS. (Feb 2001). Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol. 37:517-520.
• Cockerill GW; Huehns TY; Weerasinghe A; Stocker C; Lerch PG; Miller NE; Haskard DO. (2 Jan 2001). Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation. 103:108-112.
• Landis RC; Asimakopoulos G; Poullis M; Thompson R; Nourshargh S; Haskard DO; Taylor KM. (2001). Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery. Heart Surg Forum. 4 Suppl 1:S35-S39.
• Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO. (Jan 2001). Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis. Arthritis Rheum. 44:138-150. DOI.
• Russell AI; Lawson WA; Haskard DO. (2001). Potential new therapeutic options in Behçet's syndrome. BioDrugs. 15:25-35.
• Pickering MC; Haskard DO. (1 Dec 2000). False-positive results obtained using the Mantoux test in Behcet's syndrome: comment on the article by Garcia-Porrua et al. ARTHRITIS AND RHEUMATISM. 43:2855-2855. Author weblink DOI.
• Pickering MC; Haskard DO. (Dec 2000). False-positive results obtained using the Mantoux test in Behçet's syndrome: comment on the article by García-Porrúa et al. Arthritis Rheum. 43:2855-2856. DOI.
• Larbi KY; Allen AR; Tam FW; Haskard DO; Lobb RR; Silva PM; Nourshargh S. (15 Nov 2000). VCAM-1 has a tissue-specific role in mediating interleukin-4-induced eosinophil accumulation in rat models: evidence for a dissociation between endothelial-cell VCAM-1 expression and a functional role in eosinophil migration. Blood. 96:3601-3609.
• Asimakopoulos G; Taylor KM; Haskard DO; Landis RC. (Nov 2000). Inhibition of neutrophil L-selectin shedding: a potential anti-inflammatory effect of aprotinin. Perfusion. 15:495-499.
• Lidington EA; Rao RM; Marelli-Berg F; Jat P; Haskard DO; Mason JC. (31 Oct 2000). Establishment and characterisation of a conditionally transformed immortalised murine cardiac endothelial cell line isolated from H2kb-tsA58 transgenic mice. CIRCULATION. 102:329-329. Author weblink.
• Malik IS; Danesh J; Papacosta O; Bhatia VK; Haskard DO; Whincup P. (31 Oct 2000). Prognostic value of soluble adhesion molecules in predicting future CHD events: Prospective data from the British Regional Heart Study. CIRCULATION. 102:865-865. Author weblink.
• Lidington EA; Haskard DO; Mason JC. (15 Oct 2000). Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury. Blood. 96:2784-2792.
• Lidington EA; Haskard DO; Mason JC. (15 Oct 2000). Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury. BLOOD. 96:2684-2692.
• Wahid S; Blades MC; De Lord D; Brown I; Blake G; Yanni G; Haskard DO; Panayi GS; et alPitzalis C. (Oct 2000). Tumour necrosis factor-alpha (TNF-alpha) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice. Clin Exp Immunol. 122:133-142.
• Rao RM; Mason JC; Haskard DO. (1 Sep 2000). HLA B27 amongst patients referred for evaluation of Behcet's Syndrome. ARTHRITIS AND RHEUMATISM. 43:S363-S363. Author weblink.
• Rao RM; Clarke JL; Robinson MK; Landis C; Haskard DO. (1 Sep 2000). The E-selectin S128R polymorphism enhances tethering and firm adhesion of myeloid cell lines under flow. ARTHRITIS AND RHEUMATISM. 43:S89-S89. Author weblink.
• Mason JC; Ladington EA; Haskard DO. (1 Sep 2000). VEGF and bFGF act independently and synergistically to induce decay-accelerating factor expression and enhance endothelial cell cytoprotection. ARTHRITIS AND RHEUMATISM. 43:S90-S90. Author weblink.
• Stocker CJ; Sugars KL; Yarwood H; Delikouras A; Lechler RI; Dorling A; Landis RC; Morley BJ; et alHaskard DO. (27 Aug 2000). Cloning of porcine intercellular adhesion molecule-1 and characterization of its induction on endothelial cells by cytokines. Transplantation. 70:579-586.
• Asimakopoulos G; Thompson R; Nourshargh S; Lidington EA; Mason JC; Ratnatunga CP; Haskard DO; Taylor KM; et alLandis RC. (Aug 2000). An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg. 120:361-369. DOI.
• Yagnik DR; Hillyer P; Marshall D; Smythe CD; Krausz T; Haskard DO; Landis RC. (Aug 2000). Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout. Arthritis Rheum. 43:1779-1789. DOI.
• Chambers JC; Haskard DO; Kooner JS. (1 Aug 2000). Physiological basis of vascular dysfunction in Behcet's Disease. EUROPEAN HEART JOURNAL. 21:72-72. Author weblink.
• Yarwood H; Mason JC; Mahiouz D; Sugars K; Haskard DO. (Aug 2000). Resting and activated T cells induce expression of E-selectin and VCAM-1 by vascular endothelial cells through a contact-dependent but CD40 ligand-independent mechanism. J Leukoc Biol. 68:233-242.
• Poullis M; Manning R; Laffan M; Haskard DO; Taylor KM; Landis RC. (Aug 2000). The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1. J Thorac Cardiovasc Surg. 120:370-378. DOI.
• Asimakopoulos G; Kohn A; Stefanou DC; Haskard DO; Landis RC; Taylor KM. (Apr 2000). Leukocyte integrin expression in patients undergoing cardiopulmonary bypass. Ann Thorac Surg. 69:1192-1197.
• Larbi KY; Dangerfield JP; Thompson RD; Marshall D; Haskard DO; Nourshargh S. (15 Mar 2000). P-selectin is required for IL-4-induced eosinophil migration into the mouse peritoneal cavity but not into the mouse cremaster muscle. FASEB JOURNAL. 14:A706-A706. Author weblink.
• Stocker CJ; Sugars KL; Harari OA; Landis RC; Morley BJ; Haskard DO. (15 Mar 2000). TNF-alpha, IL-4, and IFN-gamma regulate differential expression of P- and E-selectin expression by porcine aortic endothelial cells. J Immunol. 164:3309-3315.
• Haskard DO; Lidington E; Lublin D; Mason JC. (15 Mar 2000). VEGF and bFGF act independently and synergistically to enhance endothelial cell (EC) cytoprotection through upregulation of decay-accelerating factor (DAF). FASEB JOURNAL. 14:A707-A707. Author weblink.
• Pickering MC; Haskard DO. (Mar 2000). Behçet's syndrome. J R Coll Physicians Lond. 34:169-177.
• Harari OA; McHale JF; Marshall D; Ahmed S; Brown D; Askenase PW; Haskard DO. (15 Dec 1999). Endothelial cell E- and P-selectin up-regulation in murine contact sensitivity is prolonged by distinct mechanisms occurring in sequence. J Immunol. 163:6860-6866.
• Asimakopoulos G; Thompson RD; Nourshargh S; Lidington EA; Mason JC; Ratnatunga CP; Haskard DO; Taylor KM; et alLandis RC. (2 Nov 1999). Aprotinin inhibits leukocyte transmigration across endothelium. CIRCULATION. 100:611-611. Author weblink.
• Cockerill GW; Huehns TY; Miller NE; Haskard DO. (2 Nov 1999). Exogenous reconstituted high-density lipoprotein (HDL) discoidal particles ablate the IL1-induced expression of E-selectin in microvascular endothelium in a porcine model of acute inflammation in vivo. CIRCULATION. 100:813-813. Author weblink.
• Chambers JC; Haskard DO; Kooner JS. (2 Nov 1999). Vascular endothelial function and oxidant stress mechanisms in patients with Behcet's disease. CIRCULATION. 100:212-212. Author weblink.
• Cockerill GW; Huehns TY; Miller NE; Haskard DO. (1 Nov 1999). High-density lipoproteins inhibit ILI-induced expression of E-selectin on porcine microvascular endothelial cells in vivo. ATHEROSCLEROSIS. 147:209-209. Author weblink.
• Jäger HR; Albrecht T; Curati-Alasonatti WL; Williams EJ; Haskard DO. (Oct 1999). MRI in neuro-Behçet's syndrome: comparison of conventional spin-echo and FLAIR pulse sequences. Neuroradiology. 41:750-758.
• McHale JF; Harari OA; Marshall D; Haskard DO. (1 Oct 1999). TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J Immunol. 163:3993-4000.
• Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO. (1 Sep 1999). Endothelial cell (EC) decay accelerating factor (DAF) is induced by vascular endothelial growth factor (VEGF) is cytoprotective against activated complement and may be involved in regulating EC proliferation in chronic synovitis. ARTHRITIS AND RHEUMATISM. 42:S397-S397. Author weblink.
• Cockerill GW; Heuyns T; Miller NE; Haskard DO. (1 Sep 1999). Exogenous reconstituted high-density lipoprotein (HDL) discoidal particles ablate the IL1-induced expression of E-selectin in microvascular endothelium in a porcine model of acute inflammation in vivo. ATHEROSCLEROSIS. 146:S19-S19. Author weblink.
• Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO. (1 Sep 1999). Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition. Blood. 94:1673-1682.
• Baker CS; Rimoldi O; Camici PG; Barnes E; Chacon MR; Huehns TY; Haskard DO; Polak JM; et alHall RJ. (15 Aug 1999). Repetitive myocardial stunning in pigs is associated with the increased expression of inducible and constitutive nitric oxide synthases. Cardiovasc Res. 43:685-697.
• Malik IS; Haskard DO. (Jul 1999). Soluble adhesion molecules in ischaemic heart disease. Eur Heart J. 20:990-991. DOI.
• Allen AR; McHale J; Smith J; Cook HT; Karkar A; Haskard DO; Lobb RR; Pusey CD. (1 May 1999). Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury. J Immunol. 162:5519-5527.
• Ussov WY; Peters AM; Chapman PT; Ttofi A; Mason JC; Haskard DO; Hughes JM. (May 1999). Pulmonary granulocyte kinetics in relation to endothelial and granulocyte activation. Clin Sci (Lond). 96:525-531.
• Harari OA; Wickham TJ; Stocker CJ; Kovesdi I; Segal DM; Huehns TY; Sarraf C; Haskard DO. (May 1999). Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin. Gene Ther. 6:801-807. DOI.
• Davies D; Larbi K; Allen A; Sanz M; Weg VB; Haskard DO; Lobb RR; Nourshargh S. (May 1999). VCAM-1 contributes to rapid eosinophil accumulation induced by the chemoattractants PAF and LTB4: evidence for basal expression of functional VCAM-1 in rat skin. Immunology. 97:150-158.
• Cockerill GW; Saklatvala J; Ridley SH; Yarwood H; Miller NE; Oral B; Nithyanathan S; Taylor G; et alHaskard DO. (Apr 1999). High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2. Arterioscler Thromb Vasc Biol. 19:910-917.
• Oral HB; Arancibia-Cárcamo CV; Haskard DO; George AJ. (1 Feb 1999). A method for determining the cytoprotective effect of catalase in transiently transfected cell lines and in corneal tissue. Anal Biochem. 267:196-202. DOI.
• McHale JF; Harari OA; Marshall D; Haskard DO. (1 Feb 1999). Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-alpha. J Immunol. 162:1648-1655.
• Mahiouz DL; Aichinger G; Haskard DO; George AJ. (15 Mar 1998). Expression of recombinant anti-E-selectin single-chain Fv antibody fragments in stably transfected insect cell lines. J Immunol Methods. 212:149-160.
• Arancibia-Cárcamo CV; Oral HB; Haskard DO; Larkin DF; George AJ. (15 Jan 1998). Lipoadenofection-mediated gene delivery to the corneal endothelium: prospects for modulating graft rejection. Transplantation. 65:62-67.
• Oral HB; George AJ; Haskard DO. (1998). A sensitive fluorometric assay for determining hydrogen peroxide-mediated sublethal and lethal endothelial cell injury. Endothelium. 6:143-151.
• Southcott AM; Hemingway I; Lorimer S; Sugars K; Hellewell PG; Black CM; Jeffery PK; Gearing AJ; et alHaskard DO; du Bois RM. (Jan 1998). Adhesion molecule expression in the lung: a comparison between normal and diffuse interstitial lung disease. Eur Respir J. 11:91-98.
• Harrison AA; Stocker CJ; Chapman PT; Tsang YT; Huehns TY; Gundel RH; Peters AM; Davies KA; et alGeorge AJ; Robinson MK; Haskard DO. (1 Nov 1997). Expression of vascular cell adhesion molecule-1 by vascular endothelial cells in immune and nonimmune inflammatory reactions in the skin. J Immunol. 159:4546-4554.
• Mason JC; Yarwood H; Sugars K; Haskard DO. (Oct 1997). Human umbilical vein and dermal microvascular endothelial cells show heterogeneity in response to PKC activation. Am J Physiol. 273:C1233-C1240.
• Mason JC; Yarwood H; Harrison AA; Davies KAA; Haskard DO. (1 Sep 1997). Expression and regulation of complement regulatory proteins CD59 and decay-accelerating factor (DAF) on endothelial cells (EC). ARTHRITIS AND RHEUMATISM. 40:277-277. Author weblink.
• Mason JC; Yarwood H; Sugars K; Haskard DO. (1 Sep 1997). Human umbilical vein (HUVEC) and dermal microvascular EC (DMEC) demonstrate heterogeneity in responsiveness to activation of protein kinase C (PKC). ARTHRITIS AND RHEUMATISM. 40:278-278. Author weblink.
• Oral HB; Larkin DF; Fehervari Z; Byrnes AP; Rankin AM; Haskard DO; Wood MJ; Dallman MJ; et alGeorge AJ. (Jul 1997). Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther. 4:639-647. DOI.
• al-Shahi R; Mason JC; Rao R; Hurd C; Thompson EM; Haskard DO; Davies KA. (Jul 1997). Systemic lupus erythematosus, thrombocytopenia, microangiopathic haemolytic anaemia and anti-CD36 antibodies. Br J Rheumatol. 36:794-798.
• Jamar F; Chapman PT; Manicourt DH; Glass DM; Haskard DO; Peters AM. (May 1997). A comparison between 111In-anti-E-selectin mAb and 99Tcm-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis. Br J Radiol. 70:473-481.
• Chapman PT; Yarwood H; Harrison AA; Stocker CJ; Jamar F; Gundel RH; Peters AM; Haskard DO. (May 1997). Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1. Arthritis Rheum. 40:955-965. DOI.
• Bhatti MA; Haskard DO; Hodgson HJF. (1 Apr 1997). In intestinal tissue biopsies expression of E-selectin is modulated by nicotine and crude tobacco extract. GASTROENTEROLOGY. 112:A934-A934. Author weblink.
• Bhatti MA; Haskard DO; Hodgson HJF. (1 Mar 1997). Effects of nicotine on e-selectin expression in intestinal tissue biopsies in inflammatory bowel disease patients and controls. GUT. 40:F295-F295. Author weblink.
• Healy CM; Enobakhare B; Haskard DO; Thornhill MH. (Jan 1997). Raised levels of circulating VCAM-1 and circulating E-selectin in patients with recurrent oral ulceration. J Oral Pathol Med. 26:23-28.
• Binns RM; Whyte A; Licence ST; Harrison AA; Tsang YT; Haskard DO; Robinson MK. (1 Nov 1996). The role of E-selectin in lymphocyte and polymorphonuclear cell recruitment into cutaneous delayed hypersensitivity reactions in sensitized pigs. J Immunol. 157:4094-4099.
• Dorling A; Stocker C; Tsao T; Haskard DO; Lechler RI. (27 Oct 1996). In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation. 62:1127-1136.
• Chapman PT; Jamar F; Keelan ET; Peters AM; Haskard DO. (Aug 1996). Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum. 39:1371-1375.
• Mason JC; Yarwood H; Tárnok A; Sugars K; Harrison AA; Robinson PJ; Haskard DO. (15 Jul 1996). Human Thy-1 is cytokine-inducible on vascular endothelial cells and is a signaling molecule regulated by protein kinase C. J Immunol. 157:874-883.
• Litchfield TM; Smith CH; Atkinson BA; Norris PG; Elliott P; Haskard DO; Lee TH. (Jun 1996). Eosinophil infiltration into human skin is antigen-dependent in the late-phase reaction. Br J Dermatol. 134:997-1004.
• Chapman PT; Jamar F; Haskard DO; Peters AM. (1 May 1996). Imaging arthritis: Comparison between in In-111-anti-E-selectin monoclonal antibody and Tc-99m- and In-111-human immunoglobulin (HIG). JOURNAL OF NUCLEAR MEDICINE. 37:502-502. Author weblink.
• Bhatti MA; Chapman PT; Jamar F; Glass D; Haskard DO; Hodgson HJF; Peters AM. (1 May 1996). Immunolocalization of active inflammatory bowel disease (IBD) using a monoclonal antibody against E-selectin. JOURNAL OF NUCLEAR MEDICINE. 37:445-445. Author weblink.
• Haskard DO; Stocker CJ; Chapman PT; Gundel R; Tsang Y; Robinson MR; Harrison AA. (30 Apr 1996). Differential expression of VCAM-1 and E-selectin by vascular endothelial cells (EC) in immune- and non-immune cutaneous inflammatory reactions and the greater dependence of VCAM-1 on TNF alpha. FASEB JOURNAL. 10:1625-1625. Author weblink.
• Chapman PT; Jamar F; Harrison AA; Schofield JB; Peters AM; Binns RM; Haskard DO. (Apr 1996). Characterization of E-selectin expression, leucocyte traffic and clinical sequelae in urate crystal-induced inflammation: an insight into gout. Br J Rheumatol. 35:323-334.
• Bhatti MA; Chapman PT; Peters AM; Haskard DO; Hodgson HJF. (1 Apr 1996). Radioimmunoscintography with 111-indium labelled monoclonal anti-E-selectin antibody and circulating soluble E-selectin in the evaluation of inflammatory bowel disease. GASTROENTEROLOGY. 110:A864-A864. Author weblink.
• Li J; Mahiouz DL; Farthing PM; Haskard DO; Thornhill MH. (Mar 1996). Heterogeneity of ICAM-1 expression, and cytokine regulation of ICAM-1 expression, in skin and oral keratinocytes. J Oral Pathol Med. 25:112-118.
• Menagé HDUP; Sattar NK; Haskard DO; Hawk JL; Breathnach SM. (Feb 1996). A study of the kinetics and pattern of E-selectin, VCAM-1 and ICAM-1 expression in chronic actinic dermatitis. Br J Dermatol. 134:262-268.
• Binns RM; Licence ST; Harrison AA; Keelan ET; Robinson MK; Haskard DO. (Jan 1996). In vivo E-selectin upregulation correlates early with infiltration of PMN, later with PBL entry: MAbs block both. Am J Physiol. 270:H183-H193.
• Parums DV; Ashton MD; Mason JC; Haskard DO. (1 Jan 1996). Thy-1 expression by new vessels associated with atherosclerosis. JOURNAL OF PATHOLOGY. 179:A46-A46. Author weblink.
• Davies KA; Chapman PT; Norsworthy PJ; Jamar F; Athanassiou P; Keelan ET; Harrison AA; Binns RM; et alHaskard DO; Walport MJ. (15 Dec 1995). Clearance pathways of soluble immune complexes in the pig. Insights into the adaptive nature of antigen clearance in humans. J Immunol. 155:5760-5768.
• Denton CP; Bickerstaff MC; Shiwen X; Carulli MT; Haskard DO; Dubois RM; Black CM. (Nov 1995). Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol. 34:1048-1054.
• Woolley ST; Whyte A; Licence ST; Robinson MK; Haskard DO; Binns RM. (May 1995). Appearance of lymphocytes positive for E-selectin ligands during inflammatory reactions in vivo. Biochem Soc Trans. 23:158S.
• Haskard DO. (May 1995). Cell adhesion molecules in rheumatoid arthritis. Curr Opin Rheumatol. 7:229-234.
• Whyte A; Licence ST; Woolley ST; Harrison AA; Haskard DO; Binns RM. (May 1995). Endothelial selectin expression and leukocyte trafficking in cutaneous DNFB-induced delayed hypersensitivity. Biochem Soc Trans. 23:160S.
• Tsang YT; Stephens PE; Licence ST; Haskard DO; Binns RM; Robinson MK. (May 1995). Porcine E-selectin: cloning and functional characterization. Immunology. 85:140-145.
• Harrison AA; Whyte A; Licence ST; Woolley ST; Binns RM; Haskard DO. (May 1995). The kinetics of E-selectin expression and leukocyte traffic in BCG/PPD delayed hypersensitivity in the pig. Biochem Soc Trans. 23:161S.
• Chapman PT; Haskard DO. (Apr 1995). Leukocyte adhesion molecules. Br Med Bull. 51:296-311.
• Jamar F; Chapman PT; Harrison AA; Binns RM; Haskard DO; Peters AM. (Mar 1995). Inflammatory arthritis: imaging of endothelial cell activation with an indium-111-labeled F(ab')2 fragment of anti-E-selectin monoclonal antibody. Radiology. 194:843-850.
• Groves RW; Kapahi P; Barker JN; Haskard DO; MacDonald DM. (Jan 1995). Detection of circulating adhesion molecules in erythrodermic skin disease. J Am Acad Dermatol. 32:32-36.
• Woolley ST; Whyte A; Licence ST; Haskard DO; Wooding FB; Binns RM. (Jan 1995). Differences in E-selectin expression and leucocyte infiltration induced by inflammatory agents in a novel subcutaneous sponge matrix model. Immunology. 84:55-63.
• Chapman PT; Jamar F; Harrison AA; Binns RM; Peters AM; Haskard DO. (Dec 1994). Noninvasive imaging of E-selectin expression by activated endothelium in urate crystal-induced arthritis. Arthritis Rheum. 37:1752-1756.
• Meagher L; Mahiouz D; Sugars K; Burrows N; Norris P; Yarwood H; Becker-Andre M; Haskard DO. (14 Oct 1994). Measurement of mRNA for E-selectin, VCAM-1 and ICAM-1 by reverse transcription and the polymerase chain reaction. J Immunol Methods. 175:237-246.
• Burrows NP; Molina FA; Terenghi G; Clark PK; Haskard DO; Polak JM; Jones RR. (Oct 1994). Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis. J Clin Pathol. 47:939-944.
• Beynon HL; Davies KA; Haskard DO; Walport MJ. (1 Oct 1994). Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium. J Immunol. 153:3160-3167.
• WHYTE A; HASKARD DO; BINNS RM. (1 Sep 1994). INFILTRATING GAMMA-DELTA T-CELLS AND SELECTIN ENDOTHELIAL LIGANDS IN THE CUTANEOUS PHYTOHEMAGGLUTININ-INDUCED INFLAMMATORY REACTION (VOL 41, PG 31, 1993). VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY. 42:391-391. Author weblink.
• Haskard DO. (Jul 1994). The therapeutic potential of targeting adhesion molecules in rheumatoid arthritis. Cell Adhes Commun. 2:235-238.
• Tsang YT; Haskard DO; Robinson MK. (15 Jun 1994). Cloning and expression kinetics of porcine vascular cell adhesion molecule. Biochem Biophys Res Commun. 201:805-812. DOI.
• Montefort S; Lai CK; Kapahi P; Leung J; Lai KN; Chan HS; Haskard DO; Howarth PH; et alHolgate ST. (May 1994). Circulating adhesion molecules in asthma. Am J Respir Crit Care Med. 149:1149-1152.
• JAMAR F; CHAPMAN PT; HASKARD DO; PETERS AM. (1 May 1994). IMAGING OF E-SELECTIN AS A MARKER OF ENDOTHELIAL ACTIVATION IN INFLAMMATORY ARTHRITIS. JOURNAL OF NUCLEAR MEDICINE. 35:P45-P46. Author weblink.
• Whyte A; Haskard DO; Binns RM. (May 1994). Infiltrating gamma delta T-cells and selectin endothelial ligands in the cutaneous phytohaemagglutinin-induced inflammatory reaction. Vet Immunol Immunopathol. 41:31-40.
• Montefort S; Gratziou C; Goulding D; Polosa R; Haskard DO; Howarth PH; Holgate ST; Carroll MP. (Apr 1994). Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest. 93:1411-1421. DOI.
• MASON JC; YARWOOD H; MAHIOUZ D; HASKARD DO. (1 Mar 1994). ACTIVATION OF PROTEIN-KINASE-C LEADS TO MARKEDLY DIFFERENT EFFECTS ON EXPRESSION OF SURFACE-ANTIGENS BY DERMAL MICROVASCULAR ENDOTHELIAL-CELLS (DMEC) AND HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS (HUVEC). FASEB JOURNAL. 8:A132-A132. Author weblink.
• YARWOOD H; MASON JC; MAHIOUZ D; SUGARS K; HASKARD DO. (1 Mar 1994). CHARACTERIZATION OF E-SELECTIN AND VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1) INDUCTION ON HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS (HUVEC) AND DERMAL MICROVASCULAR ENDOTHELIAL-CELLS (DMEC) DURING COCULTURE WITH T-LYMPHOCYTES. FASEB JOURNAL. 8:A133-A133. Author weblink.
• Osborn L; Vassallo C; Browning BG; Tizard R; Haskard DO; Benjamin CD; Dougas I; Kirchhausen T. (Feb 1994). Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1). J Cell Biol. 124:601-608.
• Keelan ET; Harrison AA; Chapman PT; Binns RM; Peters AM; Haskard DO. (Feb 1994). Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J Nucl Med. 35:276-281.
• MASON JC; HASKARD DO. (1 Feb 1994). INCREASED LEVELS OF INTERCELLULAR-ADHESION MOLECULE-1 IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMMENT ON THE ARTICLE BY MASON ET-AL - REPLY. ARTHRITIS AND RHEUMATISM. 37:300-301. Author weblink DOI.
• Keelan ET; Licence ST; Peters AM; Binns RM; Haskard DO. (Jan 1994). Characterization of E-selectin expression in vivo with use of a radiolabeled monoclonal antibody. Am J Physiol. 266:H278-H290.
• KEELAN ETM; LICENCE ST; PETERS AM; BINNS RM; HASKARD DO. (1 Jan 1994). CHARACTERIZATION OF E-SELECTIN EXPRESSION IN-VIVO WITH USE OF A RADIOLABELED MONOCLONAL-ANTIBODY. AMERICAN JOURNAL OF PHYSIOLOGY. 266:H279-H290. Author weblink.
• Lai KN; Wong KC; Li PK; Lai CK; Chan CH; Lui SF; Chui YL; Haskard DO. (1994). Circulating leukocyte-endothelial adhesion molecules in IgA nephropathy. Nephron. 68:294-300.
• Lai CK; Wong KC; Chan CH; Ho SS; Chung SY; Haskard DO; Lai KN. (Dec 1993). Circulating adhesion molecules in tuberculosis. Clin Exp Immunol. 94:522-526.
• Pallis M; Robson DK; Haskard DO; Powell RJ. (Sep 1993). Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus. Ann Rheum Dis. 52:667-671.
• Thornhill MH; Li J; Haskard DO. (Sep 1993). Leucocyte endothelial cell adhesion: a study comparing human umbilical vein endothelial cells and the endothelial cell line EA-hy-926. Scand J Immunol. 38:279-286.
• Wellicome SM; Kapahi P; Mason JC; Lebranchu Y; Yarwood H; Haskard DO. (Jun 1993). Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol. 92:412-418.
• Kyan-Aung U; Lee TH; Haskard DO. (Jun 1993). The inhibitory effect of tenidap on leukocyte-endothelial cell adhesion. J Rheumatol. 20:1014-1019.
• GROVES RW; BARKER JNWN; HASKARD DO; BIRD C; MACDONALD DM. (1 Apr 1993). CIRCULATING ADHESION MOLECULES ARE ELEVATED IN ERYTHRODERMA. CLINICAL RESEARCH. 41:A469-A469. Author weblink.
• GROVES RW; BARKER JNWN; HASKARD DO; BIRD C; MACDONALD DM. (1 Apr 1993). CIRCULATING ADHESION MOLECULES ARE ELEVATED IN ERYTHRODERMA. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 100:576-576. Author weblink.
• GROVES RW; BARKER JNWN; HASKARD DO; BIRD C; MACDONALD DM. (1 Apr 1993). DETECTION OF CIRCULATING ADHESION MOLECULES IN ERYTHRODERMA. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 100:468-468. Author weblink.
• Mason JC; Kapahi P; Haskard DO. (Apr 1993). Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum. 36:519-527.
• MENAGE HD; SATTAR N; HASKARD DO; HAWK JLM; BREATHNACH SM. (1 Apr 1993). THE KINETICS AND PATTERN OF ADHESION MOLECULE EXPRESSION IN INDUCED LESIONS OF CHRONIC ACTINIC DERMATITIS SUGGEST DELAYED-TYPE HYPERSENSITIVITY. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 100:468-468. Author weblink.
• Beynon HL; Haskard DO; Davies KA; Haroutunian R; Walport MJ. (Feb 1993). Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol. 91:314-319.
• TSANG YTM; HASKARD DO; ROBINSON MK. (9 Jan 1993). CHARACTERIZATION OF PORCINE E-SELECTIN. JOURNAL OF CELLULAR BIOCHEMISTRY. 344-344. Author weblink.
• MONTEFORT S; CARROLL M; GRATZIOU C; HASKARD DO; HOWARTH P; HOLGATE S. (1 Jan 1993). ADHESION MOLECULE (CAM) EXPRESSION-6 HRS AFTER ENDOBRONCHIAL ALLERGEN CHALLENGE IN ASTHMATICS. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 91:346-346. Author weblink.
• Wilkinson LS; Edwards JC; Poston RN; Haskard DO. (Jan 1993). Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest. 68:82-88.
• Norris PG; Barker JN; Allen MH; Leiferman KM; MacDonald DM; Haskard DO; Hawk JL. (Oct 1992). Adhesion molecule expression in polymorphic light eruption. J Invest Dermatol. 99:504-508.
• Montefort S; Feather IH; Wilson SJ; Haskard DO; Lee TH; Holgate ST; Howarth PH. (Oct 1992). The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol. 7:393-398.
• Poston RN; Haskard DO; Coucher JR; Gall NP; Johnson-Tidey RR. (Mar 1992). Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 140:665-673.
• MONTEFORT S; FEATHER IH; WILSON SJ; HASKARD DO; LEE TH; HOLGATE ST; HOWARTH PH. (1 Mar 1992). THE EXPRESSION OF LEUKOCYTE ENDOTHELIAL ADHESION MOLECULES IS INCREASED IN PERENNIAL ALLERGIC RHINITIS. THORAX. 47:P232-P232. Author weblink.
• AUSTEN; HOLGATE ST; SCHWARTZ LB; NADEL JA; LEE TH; MCFADDEN ER; KAY AB; PLATTSMILLS TAE; et alHOGG JC; GAULDIE J; HASKARD DO. (1 Feb 1992). AIRWAY INFLAMMATION ROUND-TABLE - GENERAL DISCUSSION. AMERICAN REVIEW OF RESPIRATORY DISEASE. 145:S53-S57. Author weblink.
• Norton J; Sloane JP; al-Saffar N; Haskard DO. (Feb 1992). Expression of adhesion molecules in human intestinal graft-versus-host disease. Clin Exp Immunol. 87:231-236.
• Haskard DO; Lee TH. (Feb 1992). The role of leukocyte-endothelial interactions in the accumulation of leukocytes in allergic inflammation. Am Rev Respir Dis. 145:S10-S13.
• Keelan E; Haskard DO. (Jan 1992). CAMs and anti-CAMs. The clinical potential of cell adhesion molecules. J R Coll Physicians Lond. 26:17-24.
• WILKINSON LS; EDWARDS JCW; POSTON RN; HASKARD DO. (1 Jan 1992). CELL-POPULATIONS EXPRESSING VASCULAR CELL-ADHESION MOLECULE-1 IN NORMAL AND INFLAMED SYNOVIUM. BRITISH JOURNAL OF RHEUMATOLOGY. 31:10-10. Author weblink.
• MASON JC; KAPAHI P; WELLICOME SM; LEBRANCHU Y; YARWOOD H; HASKARD DO. (1 Jan 1992). DETECTION OF A CIRCULATING FORM OF VCAM-1 - RAISED LEVELS IN RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS AND LACK OF CORRELATION WITH LEVELS OF CIRCULATING ICAM-1. BRITISH JOURNAL OF RHEUMATOLOGY. 31:90-90. Author weblink.
• BEYNON HLC; DAVIES KAA; HASKARD DO; HAROUTONIAN R; WALPORT MJ. (1 Jan 1992). IMMUNE-COMPLEXES DIRECTLY ACTIVATE PLATELETS AND NEUTROPHILS CAUSING AN INCREASE IN ENDOTHELIAL PERMEABILITY. BRITISH JOURNAL OF RHEUMATOLOGY. 31:98-98.
• Kyan-Aung U; Haskard DO; Lee TH. (Nov 1991). Vascular cell adhesion molecule-1 and eosinophil adhesion to cultured human umbilical vein endothelial cells in vitro. Am J Respir Cell Mol Biol. 5:445-450.
• Corkill MM; Kirkham BW; Haskard DO; Barbatis C; Gibson T; Panayi GS. (Oct 1991). Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1. J Rheumatol. 18:1453-1460.
• Burrows FJ; Haskard DO; Hart IR; Marshall JF; Selkirk S; Poole S; Thorpe PE. (15 Sep 1991). Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro. Cancer Res. 51:4768-4775.
• Norton J; Sloane JP; al-Saffar N; Haskard DO. (Jul 1991). Vessel associated adhesion molecules in normal skin and acute graft-versus-host disease. J Clin Pathol. 44:586-591.
• Norris P; Poston RN; Thomas DS; Thornhill M; Hawk J; Haskard DO. (May 1991). The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol. 96:763-770.
• KINGSLEY GH; RODRIGUEZ R; HENDERSON E; HASKARD DO; HUMPHRIES M; PANAYI GS; PITZALIS C. (11 Mar 1991). RETENTION OF T-CELLS BY SYNOVIAL EXTRACELLULAR-MATRIX - THE ROLE OF VLA-ALPHA-4, VLA-ALPHA-5 AND VLA-BETA-1. FASEB JOURNAL. 5:A620-A620. Author weblink.
• Groves RW; Allen MH; Barker JN; Haskard DO; MacDonald DM. (Feb 1991). Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol. 124:117-123.
• Kyan-Aung U; Haskard DO; Poston RN; Thornhill MH; Lee TH. (15 Jan 1991). Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol. 146:521-528.
• Thornhill MH; Wellicome SM; Mahiouz DL; Lanchbury JS; Kyan-Aung U; Haskard DO. (15 Jan 1991). Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J Immunol. 146:592-598.
• Seron D; Cameron JS; Haskard DO. (1991). Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant. 6:917-922.
• Sturgess RP; Macartney JC; Makgoba MW; Hung CH; Haskard DO; Ciclitira PJ. (Dec 1990). Differential upregulation of intercellular adhesion molecule-1 in coeliac disease. Clin Exp Immunol. 82:489-492.
• GROVES RW; ALLEN MH; BARKER JNWN; HASKARD DO; MACDONALD DM. (1 Oct 1990). ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE-1 (ELAM-1) EXPRESSION IN CUTANEOUS INFLAMMATION. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 95:470-470. Author weblink.
• Thornhill MH; Haskard DO. (1 Aug 1990). IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol. 145:865-872.
• POSTON RN; HASKARD DO; COUCHER J; GALL NP. (1 Jul 1990). EXPRESSION OF THE INTERCELLULAR-ADHESION MOLECULE ICAM-1 AND THE ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULE ELAM-1 IN ATHEROSCLEROTIC PLAQUES. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 38:1046-1046. Author weblink.
• STURGESS RP; MACARTNEY JC; NELUFER JM; MAKGOBA MW; HASKARD DO; CICLITIRA PJ. (1 May 1990). INTERCELLULAR-ADHESION MOLECULE-1 EXPRESSION IN CELIAC-DISEASE. GUT. 31:A590-A590. Author weblink.
• Thornhill MH; Kyan-Aung U; Haskard DO. (15 Apr 1990). IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J Immunol. 144:3060-3065.
• Wellicome SM; Thornhill MH; Pitzalis C; Thomas DS; Lanchbury JS; Panayi GS; Haskard DO. (1 Apr 1990). A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol. 144:2558-2565.
• RUSTIN MHA; KUNAVER M; CAMBRIDGE G; HASKARD DO; DOWD PM. (1 Apr 1990). LYMPHOCYTE SUBGROUPS AND EXPRESSION OF ENDOTHELIAL-CELL ADHESION MOLECULES IN THE SKIN OF PATIENTS WITH SYSTEMIC-SCLEROSIS. CLINICAL RESEARCH. 38:A620-A620. Author weblink.
• RUSTIN MHA; KUNAVER M; CAMBRIDGE G; HASKARD DO; DOWD PM. (1 Apr 1990). LYMPHOCYTE SUBGROUPS AND EXPRESSION OF ENDOTHELIAL-CELL ADHESION MOLECULES IN THE SKIN OF PATIENTS WITH SYSTEMIC-SCLEROSIS. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 94:573-573. Author weblink.
• Thornhill MH; Kyan-Aung U; Lee TH; Haskard DO. (Feb 1990). T cells and neutrophils exhibit differential adhesion to cytokine-stimulated endothelial cells. Immunology. 69:287-292.
• BURGAN S; THORNHILL M; MORGAN PR; CHALLACOMBE SJ; HASKARD DO. (1 Apr 1989). DETECTION OF ACTIVATED ENDOTHELIAL-CELLS (EC) IN HUMAN ORAL-MUCOSA. JOURNAL OF DENTAL RESEARCH. 68:562-562. Author weblink.
• Pitzalis C; Kingsley GH; Haskard DO; Panayi GS. (Jan 1989). Comment on the article by Lasky et al. Arthritis Rheum. 32:116-117.
• Haskard DO; Strobel S; Thornhill M; Pitzalis C; Levinsky RJ. (Jan 1989). Mechanisms of lymphocyte adhesion to endothelial cells: studies using a LFA-1-deficient cell line. Immunology. 66:111-116.
• Haskard DO; Cavender D; Maliakkal D; Ziff M. (1989). T-cell adhesion to endothelial cells in systemic lupus erythematosis. Rheumatol Int. 9:33-37.
• Cavender DE; Haskard DO; Maliakkal D; Ziff M. (Nov 1988). Separation and characterization of human T lymphocytes with varying adhesiveness for endothelial cells. Cell Immunol. 117:111-126.
• Haskard DO; Panayi GS. (Oct 1988). Multiple peripheral nerve entrapment in Forestier's disease (diffuse idiopathic skeletal hyperostosis). Br J Rheumatol. 27:407-408.
• Haskard DO; Macfarlane D. (Sep 1988). Adult acquired combined immune deficiency in a patient with rheumatoid arthritis on gold. J R Soc Med. 81:548-549.
• PITZALIS C; KINGSLEY GH; PANAYI GS; HASKARD DO. (20 Mar 1988). PREFERENTIAL ACCUMULATION OF 4B4+ T-CELLS IN CHRONIC INFLAMMATIONS RELATED TO ADHESIVENESS TO ENDOTHELIAL-CELLS (EC). FASEB JOURNAL. 2:A1448-A1448. Author weblink.
• SONTHEIMER RD; CAVENDER D; HASKARD DO; GEPPERT TD; ZIFF M. (1 Apr 1987). COMPARISON OF THE IMMUNOBIOLOGICAL PROPERTIES OF DERMAL MICROVASCULAR ENDOTHELIAL-CELLS (DMEC) AND UMBILICAL VEIN ENDOTHELIAL-CELLS (UVEC). CLINICAL RESEARCH. 35:A391-A391. Author weblink.
• Silman AJ; Day SJ; Haskard DO. (Mar 1987). Factors associated with joint mobility in an adolescent population. Ann Rheum Dis. 46:209-212.
• Haskard DO; Cavender D; Fleck RM; Sontheimer R; Ziff M. (Mar 1987). Human dermal microvascular endothelial cells behave like umbilical vein endothelial cells in T-cell adhesion studies. J Invest Dermatol. 88:340-344.
• Haskard DO; Archer JR. (22 Jan 1986). Re.: Cross-reactivity of human monoclonal antibodies between solid-phase immunoassay plates and intermediate filaments. J Immunol Methods. 86:157.
• HASKARD DO; ARCHER J. (1 Jan 1986). CROSS-REACTIVITY OF HUMAN MONOCLONAL-ANTIBODIES BETWEEN SOLID-PHASE IMMUNOASSAY PLATES AND INTERMEDIATE FILAMENTS. JOURNAL OF IMMUNOLOGICAL METHODS. 86:157-157. Author weblink DOI.
• Cavender DE; Haskard DO; Joseph B; Ziff M. (Jan 1986). Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol. 136:203-207.
• CAVENDER DE; HASKARD DO; JOSEPH B; ZIFF M. (1 Jan 1986). INTERLEUKIN-1 INCREASES THE BINDING OF HUMAN LYMPHOCYTE-B AND LYMPHOCYTE-T TO ENDOTHELIAL-CELL MONOLAYERS. JOURNAL OF IMMUNOLOGY. 136:203-207. Author weblink.
• Yu CL; Haskard DO; Cavender D; Johnson AR; Ziff M. (Dec 1985). Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol. 62:554-560.
• Haskard DO; Gul V; Morgan A; Kataaha P; Staines NA; Archer JR. (Sep 1985). Human monoclonal antibodies from patients with rheumatoid arthritis: cross reactions against cellular constituents. Clin Exp Immunol. 61:496-502.
• Haskard DO; Silman AJ. (Apr 1985). Measuring devices for studying joint mobility in the normal population. Eng Med. 14:75-77.
• Haskard DO; Gul V; Archer JR. (18 Mar 1985). Cross-reactivity between solid-phase immunoassay plates and intermediate filaments demonstrated by human monoclonal antibodies. J Immunol Methods. 77:291-295.
• SILMAN AJ; HASKARD DO. (1 Jan 1985). MEASURING DEVICES FOR STUDYING JOINT MOBILITY IN THE NORMAL POPULATION. BRITISH JOURNAL OF RHEUMATOLOGY. 24:82-82. Author weblink.
• HASKARD DO; GUL V; ARCHER J; HOLBOROW EJ. (1 Jan 1985). MONOCLONAL-ANTIBODIES FROM PATIENTS WITH RHEUMATOID-ARTHRITIS. BRITISH JOURNAL OF RHEUMATOLOGY. 24:111-111. Author weblink.
• Haskard DO; Archer JR. (30 Nov 1984). The production of human monoclonal autoantibodies from patients with rheumatoid arthritis by the EBV-hybridoma technique. J Immunol Methods. 74:361-367.
• Haskard DO; Revell PA. (Sep 1984). Methods of assessing the synovial fluid cell count. Clin Rheumatol. 3:319-322.
• Kirwan JR; Haskard DO; Higgens CS. (Aug 1984). The use of sequential analysis to assess patient preference for local skin anaesthesia during knee aspiration. Br J Rheumatol. 23:210-213.
• Haskard DO; Currey HL. (Apr 1984). Gold exacerbates adjuvant arthritis in the rat. Ann Rheum Dis. 43:350-351.
• ARCHER J; STUBBS MM; HASKARD DO; GUL V. (1 Jan 1984). A MONOCLONAL-ANTIBODY IDENTIFYING THE SPECIFICITY OF AUTOANTIBODIES IN A PATIENT WITH RELAPSING POLYCHONDRITIS. BRITISH JOURNAL OF RHEUMATOLOGY. 23:138-138. Author weblink.
• Haskard DO; Higgens CS; Temple LN; Currey HL. (Aug 1983). Spontaneous rupture of the spleen in rheumatoid arthritis. Ann Rheum Dis. 42:411-414.
• Haskard DO. (Aug 1983). Successful treatment of dermatomyositis complicated by ventilatory failure. Ann Rheum Dis. 42:460-461.
• HASKARD DO; HIGGENS CS; TEMPLE LN; CURREY HLF. (1 Jan 1982). SPONTANEOUS RUPTURE OF THE SPLEEN IN RHEUMATOID-ARTHRITIS (RA). ANNALS OF THE RHEUMATIC DISEASES. 41:639-639. Author weblink.

Chapters in books

• Sennoga CA; Yeh JS; Seddon JM; Nourshargh S; Eckersley RJ; Haskard DO; Cosgrove DO; Nihoyannopoulos P. Microbulles ciblees pour I'imagerie ultrasonore. In Echographie de Contraste. 321-328. Tranquart F (ed); Correreas J-M (ed); Bouakaz A (ed). Springer, Paris (2007).

Conferences

• Ambrose N; Haskard DO. A Case Series of HLA B27 Patients with a Behcet's Like Syndrome in a UK Population. 75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 4 Nov 2011 - 9 Nov 2011. 63:S406-S406. WILEY-BLACKWELL (1 Oct 2011).
• Haskard DO. DISEASE MANAGEMENT: MANAGEMENT OF BEHCET'S SYNDROME. Annual Meeting of the British-Society-for-Rheumatology 2011, 12 Apr 2011 - 14 Apr 2011. 50:1-1. OXFORD UNIV PRESS (1 Apr 2011). Author weblink.
• Sperone A; Birdsey GM; Dryden N; Madden LE; Evans P; Mason JC; Paleolog E; Haskard DO; et alRandi AM. The Transcription Factor Erg Represses ICAM-1 Expression and Vascular Inflammation. Scientific Sessions on Arteriosclerosis, Thrombosis and Vascular Biology, 8 Apr 2010 - 10 Apr 2010. 30:E228-E228. LIPPINCOTT WILLIAMS & WILKINS (1 Nov 2010). Author weblink.
• Sperone A; Dryden N; Birdsey GM; Madden LE; Evans P; Mason JC; Boyle J; Paleolog E; et alHaskard DO; Randi AM. The transcription factor Erg represses ICAM-1 expression and vascular inflammation. 213:E17-E17. ELSEVIER IRELAND LTD (1 Nov 2010). Author weblink DOI.
• Iqbal MB; Johns M; Laffan MA; Haskard DO; Boyle JJ. Dexamethasone reduces monocyte thrombogenecity via tissue factor-dependent and tissue factor-independent pathways. 213:E6-E6. ELSEVIER IRELAND LTD (1 Nov 2010). Author weblink DOI.
• Mehta P; Laffan MA; Haskard DO. Orthopaedics and Rehabilitation [84-85]. Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British-Health-Professional-in-Rheumatology, 21 Apr 2010 - 23 Apr 2010. 49:I64-I64. OXFORD UNIV PRESS (1 Apr 2010). DOI.
• Gompels LL; Vincent T; Madden L; Lim NH; McConnell E; Mcnamee K; Haskard DO; Paleolog EM. QUANTIFYING IN VIVO FLUORESCENCE IMAGING IN MURINE ARTHRITIS BY TARGETING E-SELECTIN. Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British-Health-Professional-in-Rheumatology, 21 Apr 2010 - 23 Apr 2010. 49:I27-I27. OXFORD UNIV PRESS (1 Apr 2010).
• Zakkar M; van der Heiden K; Chaudhury H; Krams R; Haskard DO; Mason JC; Evans PC. ACTIVATION OF NF-E2 RELATED FACTOR-2 (NRF2) PROTECTS ARTERIES FROM EXHIBITING A PRO-INFLAMMATORY STATE. Spring Meeting of the British-Society-for-Cardiovascular-Research, 2 Apr 2009 - 4 Apr 2009. 95. B M J PUBLISHING GROUP (15 Nov 2009). Author weblink DOI.
• Sperone A; Birdsey GM; Dryden N; Evans P; Boyle J; Haskard DO; Mason JC; Randi AM. THE TRANSCRIPTION FACTOR ERG PREVENTS VASCULAR INFLAMMATION BY REPRESSING ICAM-1 EXPRESSION. Spring Meeting of the British-Society-for-Cardiovascular-Research, 2 Apr 2009 - 4 Apr 2009. 95. B M J PUBLISHING GROUP (15 Nov 2009). Author weblink DOI.
• Cuhlmann S; van der Heiden K; Zakkar M; Chaudhury H; Luong LA; Mason JM; Haskard DO; Krams R; et alEvans PC. HIGH SHEAR STRESS SUPPRESSES THE EXPRESSION AND ACTIVITY OF NF-KAPPAB TRANSCRIPTION FACTORS IN ARTERIAL ENDOTHELIUM. Spring Meeting of the British-Society-for-Cardiovascular-Research, 2 Apr 2009 - 4 Apr 2009. 95. B M J PUBLISHING GROUP (15 Nov 2009). Author weblink DOI.
• Chaudhury HA; Zakkar M; Boyle J; Dennis J; van der Heiden K; Luong L; Cuhlmann S; Mason JM; et alKrams R; Haskard DO; Evans PC. ENDOTHELIAL CELLS AT ATHEROSUSCEPTIBLE SITES EXPRESS ACTIVATED C-JUN N-TERMINAL KINASE WHICH INDUCES PRO-APOPTOTIC MOLECULES. Spring Meeting of the British-Society-for-Cardiovascular-Research, 2 Apr 2009 - 4 Apr 2009. 95. B M J PUBLISHING GROUP (15 Nov 2009). Author weblink DOI.
• Boyle JJ; Johns M; Mason JC; Haskard DO. MONOCYTE DIFFERENTIATION TO AN ATHEROPROTECTIVE PHENOTYPE EXPRESSING HEME OXYGENASE-1 PIVOTALLY REQUIRES A HEME-INDUCIBLE TRANS-ACTIVATING FACTOR AND IS COUNTERACTED BY THE NUCLEAR RECEPTOR REVERB. Spring Meeting of the British-Society-for-Cardiovascular-Research, 2 Apr 2009 - 4 Apr 2009. 95. B M J PUBLISHING GROUP (15 Nov 2009). Author weblink DOI.
• Boyle JJ; Leung VWY; Rizvi H; Evans PC; Haskard DO. MATRIX-BOUND AGGREGATED IGM DRIVES MACROPHAGE CYTOTOXICITY VIA MACROPHAGE SCAVENGER RECEPTOR A AND IS INCREASED IN RUPTURED PLAQUES. Spring Meeting of the British-Society-for-Cardiovascular-Research, 2 Apr 2009 - 4 Apr 2009. 95. B M J PUBLISHING GROUP (15 Nov 2009). Author weblink DOI.
• Hamdulay SS; Wang B; Haskard DO; Wheeler-Jones C; Mason J. CELECOXIB ENHANCES ENDOTHELIAL HO-1 EXPRESSION AND ACTIVITY: A NOVEL MECHANISM OF VASCULAR CYTOPROTECTION. Annual Meeting of the British-Society-of-Rheumatology, 28 Apr 2009 - 1 May 2009. 48:I33-I34. OXFORD UNIV PRESS (1 Apr 2009). Author weblink.
• Lewis MJ; Malik TH; Fossati-Jimack LM; Carassiti D; Cook TH; Haskard DO; Botto M. COMPLEMENT DYSREGULATION LINKS ACCELERATED ATHEROSCLEROSIS AND GLOMERULONEPHRITIS IN SLE. Annual Meeting of the British-Society-of-Rheumatology, 28 Apr 2009 - 1 May 2009. 48:I15-I16. OXFORD UNIV PRESS (1 Apr 2009). Author weblink.
• GROVES RW; ALLEN MH; HASKARD DO; MACDONALD DM. ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE-1 IN ACUTE AND CHRONIC ECZEMA. 9TH SYMP ON ADVANCES IN SKIN PHARMACOLOGY, 4 Oct 1990 - 6 Oct 1990. 4:85-88. KARGER (1 Jan 1991). Author weblink.
• HASKARD DO; THORNHILL MH. CYTOKINES AND THE CONTROL OF ENDOTHELIAL-CELL ADHESIVENESS FOR LEUKOCYTES IN INFLAMMATION. 2ND INTERNATIONAL CONF ON STRUCTURE AND FUNCTION OF MOLECULES INVOLVED IN LEUKOCYTE ADHESION II, 2 Oct 1991 - 6 Oct 1991. 251-255. SPRINGER-VERLAG (1 Jan 1993). Author weblink.
• Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO. IgM deficiency accelerates atherosclerosis: A potential adverse consequence of B cell depletion therapy?. 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. 58:S934-S934. (Sep 2008).
• Zakkar M; Chaudhury H; Krams R; Mason JC; Clark AR; Haskard DO; Evans PC. Map kinase phosphatase-1 suppresses endothelial activation in regions of the arterial tree that are resistant to atherosclerosis. Spring Meeting of the British-Atherosclerosis-Society on Angiogenesis and Atherosclerosis. 199:465-465. (Aug 2008).
• Birdsey GM; Dryden NH; Arnsellem V; Gebhardt F; Haskard DO; Dejana E; Mason JC; Randi AM. The transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Spring Meeting of the British-Atherosclerosis-Society on Angiogenesis and Atherosclerosis, 3 Apr 2008 - 4 Apr 2008. 199:465-465. ELSEVIER IRELAND LTD (1 Aug 2008). Author weblink DOI.
• Keenan NG; Mason JC; Maceira A; Roughton M; Assomull R; O'Hanlon R; Andrews J; Gatehouse PD; et alFirmin DN; Haskard DO; Pennell DJ. Integrated cardiac and vascular assessment in Takayasu's arteritis and systemic lupus erythematosus by cardiovascular magnetic resonance. Annual Scientific Conference of the British-Cardiovascular-Society. 94:A78-A79. (Jul 2008).
• Yeh J; Sennoga C; McConnell E; Eckersley R; Tang M; Dawson D; Boyle J; Seddon J; et alStepney A; Haskard DO; Nihoyannopoulos P. Echo identification and quantification of inflammatory molecules in the heart. Annual Scientific Conference of the British-Cardiovascular-Society. 94:A21-A22. (Jul 2008).
• Lewis MJ; Malik TH; Fossati-Jimack LM; Carassiti D; Cook TH; Haskard DO; Botto M. Lupus phenotype accelerates atherosclerosis in a novel mouse model of SLE. Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British Health Professional in Rheumatology. 47:II97-II98. (Apr 2008).
• Mason JC; Keenan N; Maceira A; Roughton M; Assomull R; O'Hanlon R; Andrews J; Firmin D; et alHaskard DO; Pennell DJ. Integrated cardiac and vascular assessment in Takayasu's arteritis and systemic lupus erythematosus using cardiovascular magnetic resonance. Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British Health Professional in Rheumatology, 22 Apr 2008 - 25 Apr 2008. 47:II101-II101. OXFORD UNIV PRESS (1 Apr 2008). Author weblink.
• Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO. Atheroprotective functions of IgM and complement C1q: do low IgM levels and impaired complement activity provide a new link between atherosclerosis and SLE?. Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British Health Professional in Rheumatology, 22 Apr 2008 - 25 Apr 2008. 47:II7-II8. OXFORD UNIV PRESS (1 Apr 2008). Author weblink.
• Hamdulay SS; Ali F; Ali N; Steinberg R; Lidington E; Haskard DO; Mason JC. Statins and rapamycin: Therapeutic synergy in vascular cytoprotection. Annual Meeting of the British-Society-of-Rheumatology. 46:I9-I9. (Apr 2007).
• Steinberg R; Harari OA; Lidington E; Boyle J; Nohadani M; Ohba M; Samarel A; Haskard DO; et alMason JC. Protein kinase C (PKC)epsilon protects human vascular endothelial cells against apoptosis through induction of Bcl-2 and inhibition of caspase-3. Annual Meeting of the British-Society-of-Rheumatology. 46:I1-I1. (Apr 2007).
• Florey O; Mason JC; Haskard DO. Anti-endothelial cell (EC) antibodies (AECA) found in SLE augment cytokine-mediated neutrophil-EC interactions under physiological flow: Cross-talk between FC gamma RIIA, G-protein coupled receptor signalling and LFA-1. Annual European Congress of Rheumatology (EULAR 2006). 65:103-104. (Jul 2006).
• Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO. Serum IgM plays an important protective role in murine atherosclerosis. Spring Meeting of the British-Atherosclerosis-Society-Medical-Sciences-Teaching-Centre, 22 Mar 2007 - 23 Mar 2007. 193:S3-S4. ELSEVIER IRELAND LTD (1 Aug 2007). Author weblink DOI.
• HASKARD DO; THORNHILL M; KYANAUNG U; KINGSLEY G; PITZALIS C; PANAYI GS. CYTOKINE INDUCED CHANGES IN THE ENDOTHELIAL-CELL SURFACE-MEMBRANE - SIGNIFICANCE FOR LYMPHOCYTE TRAFFIC IN INFLAMMATION. 7TH INTERNATIONAL CONGRESS OF IMMUNOLOGY. 780-783. (1989).
• THORNHILL M; BURGAN S; CHALLACOMBE SJ; MORGAN PR; HASKARD DO. EXPRESSION OF AN ADHESION RELATED ACTIVATION ANTIGEN ON ENDOTHELIAL-CELLS IN HUMAN ORAL MUCOSAL DISEASES. 5TH INTERNATIONAL CONGRESS OF MUCOSAL IMMUNOLOGY. 615-616. (1990).
• HASKARD DO. ADHESION MOLECULES INDUCED BY CYTOKINES ON VASCULAR ENDOTHELIAL-CELLS. INTERNATIONAL SYMP ON BIOTECHNOLOGY OF GROWTH FACTORS : VASCULAR AND NERVOUS SYSTEMS. 56-62. (1992).
• HASKARD DO; KAPAHI P; MASON JC; WELLICOME SM. LEUKOCYTE ADHESION MOLECULES IN CLINICAL MEDICINE. 6TH SYMP ON LEUKOCYTE ADHESION. 1010:329-336. (1992).
• HARRISON AA; WHYTE A; LICENCE ST; WOOLLEY ST; BINNS RM; HASKARD DO. The kinetics of E-selectin expression and leukocyte traffic in BCG/PPD delayed hypersensitivity in the pig. 653rd Meeting of the Biochemical-Society-of-London. 23:S161-S161. (May 1995).
• WHYTE A; LICENCE ST; WOOLLEY ST; HARRISON AA; HASKARD DO; BINNS RM. Endothelial selectin expression and leukocyte trafficking in cutaneous DNFB-induced delayed hypersensitivity. 653rd Meeting of the Biochemical-Society-of-London. 23:S160-S160. (May 1995).
• WOOLLEY ST; WHYTE A; LICENCE ST; ROBINSON MK; HASKARD DO; BINNS RM. Appearance of lymphocytes positive for E-selectin ligands during inflammatory reactions in vivo. 653rd Meeting of the Biochemical-Society-of-London. 23:S158-S158. (May 1995).
• Haskard DO. Pro-inflammatory adhesins. NATO Advanced Study Institute on Vascular Endothelium - Responses to Injury. 281:145-154. (1996).
• Mason JC; Lidington EA; Mankoff R; Haskard DO. Induction of decay-accelerating factor (DAF) by VEGF on vascular endothelium: involvement of a VEGF-R2, PKC alpha/epsilon, p38/JNK MARK-dependent and PI-3K-independent signaling pathway. Experimental Biology 2003 Meeting. 17:A1193-A1193. (17 Mar 2003).
• Mason JC; Ahmad SR; Lidington EA; Ohta R; Okada N; Haskard DO. The complement regulatory protein decay-accelerating factor (DAF) is unregulated on murine vascular endothelium in vitro and during nephritis in vivo. Experimental Biology 2003 Meeting. 17:A272-A272. (14 Mar 2003).
• Bhatia VK; Boyle JJ; Roberts CE; Grimsditch DC; Sadler Y; Benson G; Botto MB; Haskard DO. Influence of complement C1Q deficiency on early lesion formation in LDL receptor knock-out mice. Joint Meeting of the British-Atherosclerosis-Society/British-Society-for-Haemostasis-and-Thrombosis. 170:S3-S3. (Sep 2003).
• Bussolati B; Ahmed A; Landis C; Di Carlo F; Haskard DO; Mason JC. Bifunctional role of heme oxygenase-1 (HO-1): Support of angiogenesis riven directly by vascular endothelial growth factor (VEGF) but inhibition of angiogenesis secondary to leukocytic infiltration. 67th Annual Scientific Meeting of the American-College-of-Rheumatology/38th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. 48:S476-S476. (Sep 2003).
• Lidington E; Landis C; Steinberg I; Kinderlerer A; Ohba M; Samarel A; Haskard DO; Mason JC. A novel role for protease-activated receptor (PAR)-2 in thrombinmediated endothelial cell (EC) cytoprotection during inflammation. 68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. 50:S331-S331. (Sep 2004).
• Mason JC; Lidington E; Steinberg R; Kinderlerer A; Ohba M; Haskard DO. VEGF-induced cytoprotection of vascular endothelium is differentially regulated by cyclosporin A (CsA) and rapamycin. 68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. 50:S263-S263. (Sep 2004).
• Huang MT; Mason JC; Gerwin N; Ridley AJ; Haskard DO; Randi AM. Intercellular adhesion molecule (ICAM)-2 mediates angiogenesis via homophilic interaction. Experimental Biology 2005 Meeting/35th International Congress of Physiological Sciences. 19:A1714-A1714. (7 Mar 2005).
• Reynolds PR; Larkman DJ; Haskard DO; Hajnal JV; Kennea NL; George AJT; Edwards AD. Detection of vascular expression of E-selectin in vivo by MR imaging. 46th Annual Meeting of the European-Society-for-Pediatric-Research. 58:407-407. (Aug 2005).
• Landis C; Philippidis P; Boyle JJ; Domin J; Nadra I; Taylor KM; Haskard DO. Hemoglobin scavenging (CD163+) macrophages in atherosclerosis: an anti-inflammatory checkpoint?. 38th Annual Meeting of the Society-for-Leukocyte-Biology. 41-41. (2005).
• Thornhill M; Papagerakis S; Green GR; Dabare M; Xu X; Florey O; Haskard DO. Sialyl lewis-X expression confers endothelial binding capacity on circulating oral cancer cells. 10th International Congress on Oral Cancer. 1:115-115. (Apr 2005).
• Evans BJ; Chaturvedi N; Haskard DO; Landis RC. Persistent Timor Necrosis Factor (TNF)alpha synthesis during cutaneous inflammation in persons with diabetes. 66th Annual Meeting of the American-Diabetes-Association. 55:A24-A24. (Jun 2006).
• Steinberg R; Harari O; Lidington E; Samarel A; Ohba M; Haskard DO; Mason JC. Protein kinase C epsilon (PKC epsilon) regulates BCL-2 expression in vascular endothelial cells (EC) and protects against apoptosis. 14th International Vascular Biology Meeting. 45:192-192. (Sep 2006).
• Partridge J; Enesa K; Kinderlerer A; Johns M; Mason JC; Haskard DO; Evans PC. Shear stress modulates endothelial responses to TNF alpha by suppressing proinflammatory transcripts and enhancing cytoprotective transcripts. Joint Autumn Meeting of the British-Society-for-Cardiovascular-Research/British-Atherosclerosis-Society. 93:U182-U182. (Feb 2007).
• Kinderlerer AR; Steinberg RM; Lidington EA; Soares MP; Haskard DO; Mason JC. Heme-oxygenase-1 upregulation induces Decay-Accelerating Factor (DAF) on vascular endothelium and protects against complement-mediated injury. BSR Annual Meeting/BHPR Spring Meeting. 45:I31-I31. (Apr 2006).
• Kinderlerer AR; Johns M; Lidington EA; Boyle JJ; Haskard DO; Mason JC. Laminar shear stress upregulates the complement-regulatory protein CD59: A novel cytoprotective mechanism against complement-mediated injury on EC. BSR Annual Meeting/BHPR Spring Meeting. 45:I28-I28. (Apr 2006).
• Hamdulay SS; Cheent K; Ghosh C; Stocks J; Ghosh S; Haskard DO. Wireless capsule endoscopy in the investigation of gastro-intestinal symptoms in Behcet's Syndrome. BSR Annual Meeting/BHPR Spring Meeting, 2 May 2006 - 5 May 2006. 45:I171-I171. OXFORD UNIV PRESS (1 Apr 2006). Author weblink.
• Yun S; Leung V; Botto M; Haskard DO; Boyle JJ. CD59 protects against lesion formation in LDL receptor deficient mice: Evidence for complement activation in atherogenesis. Joint Autumn Meeting of the British-Society-for-Cardiovascular-Research/British-Atherosclerosis-Society, 21 Sep 2006 - 22 Sep 2006. 93. B M J PUBLISHING GROUP (1 Feb 2007). Author weblink.
• Birdsey GM; Amsellem V; Mason JC; Gebhardt F; Taylor KM; Haskard DO; Randi AM. The transcription factor ERG regulates angiogenesis and apoptosis. Joint Autumn Meeting of the British-Society-for-Cardiovascular-Research/British-Atherosclerosis-Society, 21 Sep 2006 - 22 Sep 2006. 93. B M J PUBLISHING GROUP (1 Feb 2007). Author weblink.
• Boyle JJ; Phiippidis P; Horncastle D; Landis RC; Haskard DO. Vulnerable plaques are characterised by distinct populations of HLADR+/CD163-and HLADR-/CD163+macrophage subtypes. 14th Meeting of the International-Society-of-Atherosclerosis, 18 Jun 2006 - 22 Jun 2006. 7:157-157. ELSEVIER IRELAND LTD (1 Jun 2006). Author weblink DOI.
• Bhatia V; Boyle JJ; Roberts CE; Sadler Y; Witztum JL; Benson G; Botto M; Haskard DO. Complement Clq plays a bidirectional role in early atherosclerotic lesions in LDL receptor knock-out mice. 189th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland, 4 Jan 2006 - 6 Jan 2006. 208:31A-31A. JOHN WILEY & SONS LTD (1 Mar 2006). Author weblink.
• Philippidis P; Boyle J; Domin J; Nadra I; Haskard DO; Taylor KM; Landis RC. Anti-inflammatory hemoglobin scavenging macrophages in atheroschlerotic plaques: A potential atheroprotective role. 78th Annual Scientific Session of the American-Heart-Association, 13 Nov 2005 - 16 Nov 2005. 112:U126-U126. LIPPINCOTT WILLIAMS & WILKINS (25 Oct 2005). Author weblink.
• Nadra I; Philippidis P; Johns M; McCarthy GM; Landis RC; Haskard DO. Calcific crystals directly induce the release of osteopontin from human macrophages via Pi3-kinase, ERK1/2 map kinase, and NFKB signalling pathways: Implications for atherogenesis and calcific vascular disease. Annual Conference of G-MEX/MICC, 23 May 2005 - 26 May 2005. 91:A14-A14. B M J PUBLISHING GROUP (1 May 2005). Author weblink.
• Haskard DO; Bhatia V; Boyle JJ; Mason JC; Botto M. Role of complement and complement regulatory proteins in atherosclerosis. 75th Congress of the European-Atherosclerosis-Society, 23 Apr 2005 - 26 Apr 2005. 6:39-39. ELSEVIER IRELAND LTD (1 Apr 2005). Author weblink DOI.
• Lidington EA; Steinberg R; Kinderlerer A; Landis C; Ohba M; Samarel A; Haskard DO; Mason JC. A role for protease-activated receptor-2 in thrombin-mediated cytoprotection of vascular endothelium. Joint Meeting of the British-Society-for-Rheumatology/Deutsche-Gesellschaft-fur-Rheumatologie and Spring Meeting of the British-Health-Professionals-in-Rheumatology, 19 Apr 2005 - 22 Apr 2005. 44:I21-I22. OXFORD UNIV PRESS (1 Mar 2005). Author weblink.
• Evans BJ; Hogg N; Taylor KM; Haskard DO; Landis RC. LFA-1 shedding from transmigrated leukocytes: A novel finding with possible implications for the role of integrins in atherogenesis. 77th Scientific Meeting of the American-Heart-Association, 7 Nov 2004 - 10 Nov 2004. 110:253-253. LIPPINCOTT WILLIAMS & WILKINS (26 Oct 2004). Author weblink.
• Nadra I; Boccaccini AR; Whelan C; McCarthy GM; Landis RC; Haskard DO. Basic calcium phosphate crystal induced human fibroblast mitogenesis is tightly correlated to macrophage pro-inflammatory activation which is determined by the same particle characteristics. 68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 16 Oct 2004 - 21 Oct 2004. 50:S333-S333. WILEY-LISS (1 Sep 2004). Author weblink.
• Nadra I; Philippidis P; Mason JC; McCarthy GM; Landis RC; Haskard DO. Basic calcium phosphate crystals induce human macrophage TNF alpha release through PKC alpha mediated ERK-1/2 MAP kinase activation. 68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 16 Oct 2004 - 21 Oct 2004. 50:S333-S333. WILEY-LISS (1 Sep 2004). Author weblink.
• Nadra I; Philippidis P; Johns M; McCarthy GM; Landis RC; Haskard DO. Basic calcium phosphate crystals induce the release of osteopontin from human monocyte derived macrophages. 68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 16 Oct 2004 - 21 Oct 2004. 50:S246-S247. WILEY-LISS (1 Sep 2004). Author weblink.
• Malik LS; Al-Nahhas A; Peters AM; Haskard DO. Imaging musculoskeletal infection with (111)indium labeled anti-E-selectin monoclonal antibody 1.2B6 as an alternative to (111)indium labeled leukocyte scintigraphy. 68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 16 Oct 2004 - 21 Oct 2004. 50:S263-S263. WILEY-LISS (1 Sep 2004). Author weblink.
• Philippidis P; Taylor KM; Haskard DO; Landis RC. Anti-inflammatory monocytes are induced following cardiopulmonary bypass surgery. Annual Conference of the British-Cardiac-Society, 24 May 2004 - 27 May 2004. 90:A29-A29. B M J PUBLISHING GROUP (1 May 2004). Author weblink.
• Day JRS; Haskard DO; Taylor KM; Landis RC. Aprotinin prevents platelet dysfunction after cardiopulmonary bypass (CPB) by protecting PAR1. Annual Conference of the British-Cardiac-Society, 24 May 2004 - 27 May 2004. 90:A29-A29. B M J PUBLISHING GROUP (1 May 2004). Author weblink.
• Nadra I; Philippidis P; Mason JC; McCarthy GM; Landis RC; Haskard DO. Atherosclerotic calcification as a hidden source of inflammation: Protein kinase C alpha and epsilon, ERK-1/2 and NF kappa B signalling pathways mediate calcium hydroxyapatite crystal induced TNF alpha secretion by human macrophages. Annual Conference of the British-Cardiac-Society, 24 May 2004 - 27 May 2004. 90:A11-A11. B M J PUBLISHING GROUP (1 May 2004). Author weblink.
• Nadra I; Philippidis P; Mason JC; McCarthy GM; Landis RC; Haskard DO. Calcitic crystals induced pro-inflammatory activation of human macrophages through NF kappa B, ERK-1/2, JNK but not p38 signalling pathways. Spring Meeting of the British-Athersclerosis-Society, 25 Mar 2004 - 26 Mar 2004. 174:S4-S5. ELSEVIER SCI IRELAND LTD (1 May 2004). Author weblink.
• Roberts CE; Sheridan DJ; Blomley MJ; Nihayannopoulos P; Haskard DO. Characterisation of lung inflammation in a murine myocardial infarction model of heart failure. Annual Conference of the British-Cardiac-Society, 24 May 2004 - 27 May 2004. 90:A49-A49. B M J PUBLISHING GROUP (1 May 2004). Author weblink.
• Day JRS; Malik IS; Weerasinghe A; Poullis M; Nadra I; Haskard DO; Taylor KM; Landis RC. Distinct yet complementary roles of IIB/IIIA inhibitors and heparin during platelet activation: Implications for restenosis following percutaneous coronary interventions (PCI). Annual Conference of the British-Cardiac-Society, 24 May 2004 - 27 May 2004. 90:A18-A18. B M J PUBLISHING GROUP (1 May 2004). Author weblink.
• Philippidis P; Nadra I; Taylor KM; Haskard DO; Landis RC. Haemoglobin scavenging human macrophages elicit haptoglobin phenotype dependent anti-inflammatory, atheroprotective effects. Spring Meeting of the British-Athersclerosis-Society, 25 Mar 2004 - 26 Mar 2004. 174:S5-S5. ELSEVIER SCI IRELAND LTD (1 May 2004). Author weblink.
• Philippidis P; Nadra I; Evans B; Taylor KM; Haskard DO; Landis RC. Susceptibility to diabetic cardiovascular disease is influenced by haptoglobin (Hp) phenotype dependent anti-inflammatory pathways in macrophages (M phi). Annual Conference of the British-Cardiac-Society, 24 May 2004 - 27 May 2004. 90:A56-A56. B M J PUBLISHING GROUP (1 May 2004). Author weblink.
• Nadra I; Florey OJ; Mason JC; McCarthy GM; Haskard DO; Landis RC. Coronary artery calcificationas as a pro-inflammatory trigger: Calcium hydroxyapatite induces secretion of pro-inflammatory cytokines by human macrophages via a protein kinase C alpha and epsilon pathway and leads to endothelial activation. 76th Annual Scientific Session of the American-Heart-Association, 7 Nov 2003 - 12 Nov 2003. 108:301-301. LIPPINCOTT WILLIAMS & WILKINS (28 Oct 2003). Author weblink.
• Haskard DO; Berlaimont V; Mandryko V; Naoumova R; Randi A. Atorvastatin leads to altered mononuclear cell gene expression prior to changes in serum low density cholesterol and triglyceride levels. 67th Annual Scientific Meeting of the American-College-of-Rheumatology/38th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 23 Oct 2003 - 28 Oct 2003. 48:S230-S230. WILEY-LISS (1 Sep 2003). Author weblink.
• Kinderlerer AR; Mankoff R; Maxwell PH; Haskard DO; Mason JC. Atorvastatin protects vascular endothelium from complement-mediated ischaemia-reperfusion injury by upregulation of complement regulatory proteins. Joint Meeting of the British-Atherosclerosis-Society/British-Society-for-Haemostasis-and-Thrombosis, 19 Sep 2003. 170:S13-S13. ELSEVIER SCI IRELAND LTD (1 Sep 2003). Author weblink.
• Haskard DO; Nadra I; Mason JC; McCarthy GM; Florey OJ; Landis RC. Basic calcium phosphate crystals induce secretion of proinflammatory cytokines by human macrophages through protein kinase C alpha and epsilon mediated pathways and lead to endothelial activation. 67th Annual Scientific Meeting of the American-College-of-Rheumatology/38th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 23 Oct 2003 - 28 Oct 2003. 48:S684-S685. WILEY-LISS (1 Sep 2003). Author weblink.
• Nadra I; Florey OJ; Philippidis P; Mason JC; McCarthy GM; Haskard DO; Landis RC. Protein kinase C alpha and epsilon dependent activation of macrophages by calcium hydroxyapatite crystals: A hidden source of inflammation in the calcified coronary artery. Joint Meeting of the British-Atherosclerosis-Society/British-Society-for-Haemostasis-and-Thrombosis, 19 Sep 2003. 170:S13-S14. ELSEVIER SCI IRELAND LTD (1 Sep 2003). Author weblink.
• Johns M; Lewis MJ; Smythe C; Haskard DO. Suppressive subtractive hybridisation analysis of TNFa-regulated gene expression in porcine aortic endothelial cells. 7th Congress of the International-Xenotransplantation-Association, 2003. 10:511-511. BLACKWELL MUNKSGAARD (1 Sep 2003). Author weblink.
• Philippidis P; Mason JC; Evans B; Nadra I; Taylor KM; Haskard DO; Landis RC. The hemoglobin scavenger receptor CD163 on human macrophages is linked to athero-protective IL-10 and HO-1 effector pathways. Joint Meeting of the British-Atherosclerosis-Society/British-Society-for-Haemostasis-and-Thrombosis, 19 Sep 2003. 170:S14-S14. ELSEVIER SCI IRELAND LTD (1 Sep 2003). Author weblink.
• Kinderlerer AR; Mankoff R; Maxwell PH; Haskard DO; Mason JC. Upregulation of membrane-bound complement regulatory proteins by atorvastatin protects vascular endothelium against complement-mediated injury during hypoxia-reoxygenation. 67th Annual Scientific Meeting of the American-College-of-Rheumatology/38th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 23 Oct 2003 - 28 Oct 2003. 48:S690-S690. WILEY-LISS (1 Sep 2003). Author weblink.
• Nadra I; Florey OJ; Mason JC; McCarthy GM; Haskard DO; Landis RC. Coronary calcification as a pro-inflammatory trigger: Calcium hydroxyapatite stimulates human monocyte/macrophage secretion of pro-inflammatory cytokines leading to endothelial activation. Annual Scientific Conference of the British-Cardiac-Society, 28 Apr 2003 - 1 May 2003. 89:A47-A48. B M J PUBLISHING GROUP (1 May 2003). Author weblink.
• Mason JC; Ahmed Z; Mankoff R; Lidington E; Randi AM; Haskard DO. Statin-induced expression of complement inhibitory proteins protects vascular endothelium against complement-mediated injury. American-Heart-Association Abstracts From Scientific Sessions, 17 Nov 2002 - 20 Nov 2002. 106:85-85. LIPPINCOTT WILLIAMS & WILKINS (5 Nov 2002). Author weblink.
• Mason JC; Ahmad SR; Lidington EA; Ohta R; Okada N; Robson M; Davies KA; Haskard DO. Expression and regulation of the complement regulatory protein decay-accelerating factor (DAF) on murine vascular endothelium. 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 24 Oct 2002 - 29 Oct 2002. 46:S422-S422. WILEY-LISS (1 Sep 2002). Author weblink.
• Yagnik DR; Mason JC; Landis RC; Haskard DO. Monosodium-urate (MSU) crystal-stimulated macrophages suppress monocyte-mediated expression of endothelial E-selectin by a mechanism involving TGF-beta 1 - Insight into the spontaneous resolution of leukocyte trafficking during the resolution phase of acute gout. 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 24 Oct 2002 - 29 Oct 2002. 46:S592-S592. WILEY-LISS (1 Sep 2002). Author weblink.
• WOOLLEY ST; WHYTE A; LICENCE ST; ROBINSON MK; HASKARD DO; BINNS RM. APPEARANCE OF LYMPHOCYTES POSITIVE FOR E-SELECTIN LIGANDS DURING INFLAMMATORY REACTIONS IN-VIVO. 653rd Meeting of the Biochemical-Society-of-London, 13 Sep 1994 - 16 Sep 1994. 23:S158-S158. PORTLAND PRESS (1 May 1995). Author weblink.
• WHYTE A; LICENCE ST; WOOLLEY ST; HARRISON AA; HASKARD DO; BINNS RM. ENDOTHELIAL SELECTIN EXPRESSION AND LEUKOCYTE TRAFFICKING IN CUTANEOUS DNFB-INDUCED DELAYED-HYPERSENSITIVITY. 653rd Meeting of the Biochemical-Society-of-London, 13 Sep 1994 - 16 Sep 1994. 23:S160-S160. PORTLAND PRESS (1 May 1995). Author weblink.
• HARRISON AA; WHYTE A; LICENCE ST; WOOLLEY ST; BINNS RM; HASKARD DO. THE KINETICS OF E-SELECTIN EXPRESSION AND LEUKOCYTE TRAFFIC IN BCG/PPD DELAYED-HYPERSENSITIVITY IN THE PIG. 653rd Meeting of the Biochemical-Society-of-London, 13 Sep 1994 - 16 Sep 1994. 23:S161-S161. PORTLAND PRESS (1 May 1995). Author weblink.

Patents

• Suppression of xenotransplant rejection. Patent number: WO00/31126 (PCT-International Patent Application). George A; Lechler R; Ramakha P.